Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000117242	PINK1-AS	1.31376175630004	8.82595529479942e-6	M2_vs_M1	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	LRCH3
ENSG00000125462	MIR9-1HG	-5.57808510112995	2.51810596132228e-16	M2_vs_M1	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	COL1A1
ENSG00000162888	C1orf147	-2.65217571451145	1.36137181703954e-10	M2_vs_M1	NA	NA	NA	NA	NA	EIF2D	KPNA2
ENSG00000166770	ZNF667-AS1	1.25000245819172	0.00112071977144077	M2_vs_M1	HSALNG0127764	anti_sense	Not conserved	hsa-miR-6895-5p	Alkaline phosphatase measurement; Low density lipoprotein cholesterol measurement,-	ZNF471	CELF3
ENSG00000167920	KRT10-AS1	1.07852009237317	0.00236167613243793	M2_vs_M1	HSALNG0116399	anti_sense	Q75	hsa-miR-3960	Leukocyte count,-	KRTAP4-7	GTF3C1
ENSG00000171889	MIR31HG	2.54311440882382	0.00103622900560669	M2_vs_M1	HSALNG0070362	anti_sense,sense	Q50	hsa-miR-4483,hsa-miR-6089,hsa-miR-7151-5p	Aging,High density lipoprotein cholesterol measurement,Coagulation factor v measurement,Susceptibility to shingles measurement,Thyroid preparation use measurement,Hypothyroidism,Autoimmune disease; Hypothyroidism; Thyroid preparation use measurement,Amblyopia,Macula measurement,Autoimmune thyroid disease,-	IFNE	CASP1P2
ENSG00000172965	MIR4435-2HG	1.22213528113623	2.16032160497462e-11	M2_vs_M1	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	ARL6IP1P2
ENSG00000174370	KCNJ5-AS1	2.41448916542445	1.27730453051978e-192	M2_vs_M1	NA	NA	NA	NA	NA	TP53AIP1	HOMER3
ENSG00000178803	ADORA2A-AS1	-7.83531530940396	2.60458517821619e-14	M2_vs_M1	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	C15orf48
ENSG00000180066	LINC02870	1.2814394527172699	0.014633058829664	M2_vs_M1	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	WDR81
ENSG00000181577	LINC03040	-2.79140414521633	2.68826196629908e-9	M2_vs_M1	NA	NA	NA	NA	NA	TMEM63B	CD2
ENSG00000182376	NA	2.87038777673418	0.0109609089984512	M2_vs_M1	NA	NA	NA	NA	NA	CTU2	KRT3
ENSG00000183250	LINC01547	-1.26437923583618	6.6757738209874204e-9	M2_vs_M1	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2	LY9
ENSG00000185168	LINC00482	2.83168615082957	0.00167070716408552	M2_vs_M1	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	ENSG00000243225
ENSG00000185433	LINC00158	-6.48051518829757	1.06022314251055e-29	M2_vs_M1	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	ABTB2
ENSG00000186235	LINC02610	1.46347439311029	4.12046661093381e-5	M2_vs_M1	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	ZC3HAV1L
ENSG00000188825	LINC00910	1.16199821700526	0.00153837160381758	M2_vs_M1	HSALNG0116632	integenic	Not conserved	NA	-	CCDC200	ACSS2
ENSG00000189238	LINC00943	-1.92569482334056	0.00496039729405202	M2_vs_M1	HSALNG0094963	integenic	Q50	hsa-miR-619-5p,hsa-miR-936,hsa-miR-4725-3p	NA	TMEM132B	ACSS2
ENSG00000197180	ATP6AP1-DT	1.26814316936602	1.63637505164497e-17	M2_vs_M1	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	VPS26C
ENSG00000197536	IRF1-AS1	-3.85180097241703	6.65965489841074e-102	M2_vs_M1	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	GP1BA
ENSG00000197989	SNHG12	1.10825498530097	3.35412801913418e-32	M2_vs_M1	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	TP53I11
ENSG00000203446	SUGCT-AS1	-1.06463579101271	3.0726845492614203e-15	M2_vs_M1	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	TOMM34
ENSG00000203497	PDCD4-AS1	1.06825856779997	0.0140661801147129	M2_vs_M1	HSALNG0080613	anti_sense	Q50	hsa-miR-6089	Aspartate aminotransferase measurement,-	BBIP1	SRSF8
ENSG00000203709	MIR29B2CHG	-1.82980940340182	2.5733807789058102e-67	M2_vs_M1	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	SPECC1
ENSG00000204044	SLC12A5-AS1	-1.099287787352	1.82886729215278e-6	M2_vs_M1	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	SLC26A6
ENSG00000204261	PSMB8-AS1	-1.10777996781171	1.19687052279219e-4	M2_vs_M1	HSALNG0049455	anti_sense,sense	Q75	NA	Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9	FAM169A
ENSG00000204832	ST8SIA6-AS1	5.51885523852054	2.09074622453502e-13	M2_vs_M1	HSALNG0076446	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6764-5p	Sleep apnea measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement,Aspartate aminotransferase measurement,-	VIM	FGL2
ENSG00000204971	NA	2.90842234680387	6.797178401342389e-25	M2_vs_M1	HSALNG0085534	integenic	Not conserved	hsa-miR-412-3p,hsa-miR-6769b-5p	NA	PHOX2A	BICDL1
ENSG00000205057	CLLU1-AS1	-2.87588463406949	4.18727940968881e-26	M2_vs_M1	NA	NA	NA	NA	NA	BTG1	BTG2
ENSG00000205414	NA	3.53940397530642	2.59170067051141e-25	M2_vs_M1	HSALNG0144931	anti_sense	Q50	NA	NA	SNX20	DENND2D
ENSG00000205444	KU-MEL-3	-6.5524648690009	7.35141471516508e-6	M2_vs_M1	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL	BDNF
ENSG00000205611	LINC01597	-5.04555730447203	0.0274343436832197	M2_vs_M1	HSALNG0129452	integenic	Not conserved	hsa-miR-4433a-3p	-	DEFB116	SZRD1
ENSG00000205837	LINC00487	-5.68128955498387	2.64486170889157e-17	M2_vs_M1	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	TOR1B
ENSG00000205885	C1RL-AS1	-4.16550667517368	8.60948935696213e-52	M2_vs_M1	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	WNT5A
ENSG00000206337	HCP5	-1.32692472311611	5.78149910970095e-69	M2_vs_M1	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	OGFR
ENSG00000206344	HCG27	-1.75330287142296	0.00320211414185467	M2_vs_M1	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	RFXANK
ENSG00000214401	KANSL1-AS1	1.02155027230764	5.4951520083224e-8	M2_vs_M1	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ARHGAP12
ENSG00000214870	LINC02981	1.74206848971901	1.13214760628304e-8	M2_vs_M1	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	VAT1L
ENSG00000214922	HLA-F-AS1	-1.35426391965684	1.99524832094837e-5	M2_vs_M1	HSALNG0049088	anti_sense	Not conserved	hsa-miR-575,hsa-miR-8485	Age at menopause,Cytokine measurement,Psoriatic arthritis,Bmi-adjusted waist-hip ratio; Hodgkins lymphoma, mixed cellularity,Lung carcinoma,Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement,Urate measurement,-	ZFP57	ENSG00000254317
ENSG00000215244	LINC02649	-1.0690260095462	0.0198190248662481	M2_vs_M1	HSALNG0142500	integenic	Not conserved	NA	Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3	NPR1
ENSG00000215458	AATBC	2.15224294068819	2.81189078708521e-31	M2_vs_M1	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	PAQR4
ENSG00000216863	LY86-AS1	2.58689647067063	8.44095652370297e-51	M2_vs_M1	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	ALDH3A1
ENSG00000219665	ZNF433-AS1	2.16142281502354	2.31325077166014e-15	M2_vs_M1	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA	FHOD1
ENSG00000222017	NA	-5.04555456185235	0.0216668668051953	M2_vs_M1	HSALNG0021397	anti_sense,sense	Not conserved	hsa-miR-4268	Monocyte count,Red blood cell distribution width,Circadian rhythm,Chronotype measurement,Rheumatoid arthritis,Platelet count,Brain aneurysm,Body mass index,-	MARS2	LGALS14
ENSG00000222032	NA	5.74853460443758	0.00433058258963099	M2_vs_M1	HSALNG0023343	integenic	Q75	hsa-miR-6865-5p	Body height,-	COL6A3	ADAMTS8
ENSG00000222042	NA	-6.22197012657631	2.60522427175326e-4	M2_vs_M1	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	RN7SKP26
ENSG00000223704	LINC01422	1.41589013748521	0.012103088464581	M2_vs_M1	HSALNG0134677	integenic	Not conserved	hsa-miR-7108-3p	-	CRYBA4	ENSG00000289507
ENSG00000223749	MIR503HG	-1.95094896092105	9.14122271224817e-6	M2_vs_M1	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1	SEMA3A
ENSG00000223901	NA	-2.55260006573747	2.1445746021701498e-11	M2_vs_M1	HSALNG0133720	anti_sense	Q50	NA	-	YBEY	TNFAIP8
ENSG00000223949	ROR1-AS1	2.41416099805847	7.624893622870771e-93	M2_vs_M1	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	PTPRO
ENSG00000223969	NA	-1.32686230140924	0.00125831374446989	M2_vs_M1	HSALNG0059467	anti_sense	Q75	NA	-	FAM237B	NAA20
ENSG00000224116	INHBA-AS1	-3.42930249769281	0.00290767568155436	M2_vs_M1	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	SLC39A13
ENSG00000224186	PITX1-AS1	1.38680154647908	6.82377145868527e-5	M2_vs_M1	HSALNG0045024	integenic	Not conserved	NA	NA	CATSPER3	AATF
ENSG00000224307	LINC02975	3.37771872508849	1.0029128059099499e-131	M2_vs_M1	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	SCIN
ENSG00000224397	PELATON	1.07947652494625	2.0134400020062497e-42	M2_vs_M1	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	YBX1
ENSG00000224652	LINC00885	2.18823368045075	6.05153727359487e-9	M2_vs_M1	HSALNG0031897	integenic	Not conserved	hsa-miR-920,hsa-miR-3169,hsa-miR-6133	Hba1c measurement,Mean corpuscular volume; Erythrocyte count,-	SLC51A	CDNF
ENSG00000224666	ETV7-AS1	-5.41379852606972	0.00528784389313135	M2_vs_M1	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	ENSG00000287335
ENSG00000224995	LINC01526	2.40776184797298	4.61173349061368e-6	M2_vs_M1	HSALNG0051540	integenic	Q75	hsa-miR-761,hsa-miR-3619-5p,hsa-miR-6132	Loneliness measurement,Basophil count; Basophil percentage of leukocytes; Monocyte percentage of leukocytes,Coronary artery disease,Bmi-adjusted waist circumference,Cognitive function measurement,Body height,Myocardial infarction,Central corneal thickness,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,Basophil count; Basophil percentage of leukocytes,Monocyte percentage of leukocytes,Central corneal thickness; Intraocular pressure measurement,Corneal resistance factor; Intraocular pressure measurement,Central corneal thickness; Corneal topography,Obsessive-compulsive disorder; Sex interaction measurement,Heel bone mineral density,-	TENT5A	URM1
ENSG00000225077	ICMT-DT	-5.70715723652819	0.00338436718298687	M2_vs_M1	HSALNG0000511	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4650-5p,hsa-miR-6089	Qt interval,Resting heart rate,-	HES3	RASSF5
ENSG00000225138	SLC9A3-AS1	1.20252740164621	1.14957201565921e-5	M2_vs_M1	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	ENSG00000281920
ENSG00000225177	NHSL1-AS1	2.91857832577163	2.98515282486082e-32	M2_vs_M1	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A	NUDT19
ENSG00000225342	LRRK2-DT	-2.76152750587465	1.24051314991278e-9	M2_vs_M1	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	COL1A1
ENSG00000225434	LINC01504	1.83126655390077	2.6910176725534102e-24	M2_vs_M1	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA	LLGL1
ENSG00000225465	RFPL1S	-1.15150615277482	0.0152989819039838	M2_vs_M1	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5	CCNY-AS1
ENSG00000225783	MIAT	-2.37231744422333	6.662480683505689e-25	M2_vs_M1	HSALNG0134655	integenic	Q50	hsa-miR-216a-3p,hsa-miR-619-5p,hsa-miR-1285-5p,hsa-miR-4496,hsa-miR-4505,hsa-miR-4690-3p,hsa-miR-4726-3p,hsa-miR-5007-5p,hsa-miR-6089,hsa-miR-6754-5p,hsa-miR-6777-3p,hsa-miR-8485	Serum igg glycosylation measurement,Rr interval,Non-hodgkins lymphoma,Grey matter density measurement,Diet measurement,Gastroesophageal reflux disease,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement; Mathematical ability,Intelligence,Lysophosphatidylethanolamine 18:1 measurement,Cognition,Electroencephalogram measurement; Theta wave measurement,Parental genotype effect measurement; Peanut allergy measurement,Covid-19; Pneumonia,Hypermetropia; Myopia,-	CRYBA4	NR1I2
ENSG00000225792	SNX10-AS1	-4.51121129279677	5.654241364886749e-75	M2_vs_M1	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	ANKRD33B
ENSG00000225886	NA	-5.26076009556017	8.36627018637802e-22	M2_vs_M1	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	ZBTB2
ENSG00000225963	NA	-1.62579367586005	2.11157633902992e-5	M2_vs_M1	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	LARP4B
ENSG00000225964	NRIR	-5.56694472707436	4.29001556848136e-60	M2_vs_M1	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	XIRP1
ENSG00000226004	LINC02528	-9.40928492056819	3.89874313780502e-39	M2_vs_M1	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	PSTPIP2
ENSG00000226067	LINC00623	-2.16183954319407	8.9976112530435e-7	M2_vs_M1	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	ITK
ENSG00000226091	LINC00937	-4.86060770045714	7.381881460842539e-84	M2_vs_M1	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	AMPD3
ENSG00000226137	BAIAP2-DT	1.84098115201276	2.43779880671779e-69	M2_vs_M1	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	MT-ND5
ENSG00000226239	NA	-5.51844847989369	0.00467170171924597	M2_vs_M1	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	LGALS14
ENSG00000226281	NA	2.54381557654341	3.7354201365268e-100	M2_vs_M1	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	BRCC3
ENSG00000226312	CFLAR-AS1	-1.3698887105039	2.38302797908471e-6	M2_vs_M1	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	TCHH
ENSG00000226328	NUP50-DT	-1.06439062744077	2.57250382356732e-16	M2_vs_M1	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	SYNC
ENSG00000226441	PLCL2-AS1	3.5590227550021	0.00802462837745537	M2_vs_M1	HSALNG0024502	anti_sense	Q75	NA	NA	TBC1D5	CCL17
ENSG00000226777	FAM30A	1.07110647520683	0.0169786687527398	M2_vs_M1	HSALNG0104257	integenic	Not conserved	NA	NA	TMEM121	LINC00863
ENSG00000226822	LINC02785	1.86333317160458	7.33355841591972e-14	M2_vs_M1	HSALNG0005787	anti_sense	Q50	hsa-miR-1224-5p,hsa-miR-4508,hsa-miR-4638-3p,hsa-miR-6089	Bipolar disorder,Neutrophil count,Waist-hip ratio,Heel bone mineral density,Hba1c measurement,Hemoglobin a1 measurement,Mean corpuscular volume,Covid-19,Growth-regulated alpha protein measurement,Herpes zoster,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Forced expiratory volume; Response to bronchodilator,-	NBPF6	SLC39A6
ENSG00000226862	NA	4.75229079068319	0.0313725103831644	M2_vs_M1	HSALNG0009734	anti_sense,sense	Q75	hsa-miR-328-3p,hsa-miR-574-5p,hsa-miR-4453,hsa-miR-4486	Cortical surface area measurement,-	PPP1R12B	ENSG00000274422
ENSG00000226950	DANCR	1.03686277275688	5.80868627305576e-6	M2_vs_M1	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	PAK1IP1
ENSG00000227017	NA	-4.5179993548987	2.17675731550293e-7	M2_vs_M1	HSALNG0056985	integenic	Q50	NA	-	FKBP14	VIM
ENSG00000227039	ITGB2-AS1	-2.14149506755021	8.600210283462258e-31	M2_vs_M1	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9	CARD19
ENSG00000227066	NA	-2.69488259508166	6.00610864765732e-4	M2_vs_M1	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	ERF
ENSG00000227155	DOCK8-AS2	-1.13461424802345	0.011888869769443	M2_vs_M1	HSALNG0069538	anti_sense	Q90	hsa-miR-4268,hsa-miR-4743-3p	Bilirubin measurement,Hair morphology measurement,-	ZNG1A	YWHAH
ENSG00000227392	HPN-AS1	-7.36096177823923	2.4605855614477904e-9	M2_vs_M1	HSALNG0125567	anti_sense	Not conserved	NA	NA	LGI4	FBLN7
ENSG00000227502	MROCKI	-3.57652984665383	3.6516859726975594e-25	M2_vs_M1	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	TNFRSF25
ENSG00000227531	NA	-2.32799159778638	5.94910763641892e-4	M2_vs_M1	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	MTF2
ENSG00000227544	LINC03013	3.53921515190607	0.00558942322079341	M2_vs_M1	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	RYK
ENSG00000227917	NA	-2.48061179441958	0.0202192297153735	M2_vs_M1	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	PDXDC1
ENSG00000228013	IL6R-AS1	-2.42039506597419	1.62184719653495e-8	M2_vs_M1	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE	MDGA1
ENSG00000228022	HCG20	-5.41473308718497	0.00980872592986718	M2_vs_M1	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ENSG00000258509
ENSG00000228382	ITPKB-IT1	3.17925248085141	0.0351984908144727	M2_vs_M1	HSALNG0011101	sense	Q75	NA	NA	ITPKB	ETAA1
ENSG00000228536	LYPLAL1-AS1	5.34830354160974	0.014060036847088	M2_vs_M1	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B	DUOX2
ENSG00000228624	HDAC2-AS2	1.43950362489553	4.96311025589114e-7	M2_vs_M1	HSALNG0052943	integenic	Not conserved	NA	NA	MARCKS	SORT1
ENSG00000228742	LINC02577	1.87329055901819	8.0101528229407e-4	M2_vs_M1	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	ZFAND6
ENSG00000228863	NA	-3.0556270088786	2.0226620283071298e-11	M2_vs_M1	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7	FAM217B
ENSG00000228923	NA	-5.87400256349863	4.3303932100426e-4	M2_vs_M1	HSALNG0134504	sense	Q75	hsa-miR-6810-3p	Serum gamma-glutamyl transferase measurement	UPB1	LGALS14
ENSG00000229140	CCDC26	5.50081816326369	1.22344732606309e-62	M2_vs_M1	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	METTL9
ENSG00000229272	LINC03036	4.18138478087803	9.19983769072046e-12	M2_vs_M1	HSALNG0081008	integenic	Not conserved	NA	NA	EIF3A	CCDC86
ENSG00000229331	GK-IT1	-3.19629410610042	1.48932404388873e-4	M2_vs_M1	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p	NA	GK	TAF1C
ENSG00000229337	NA	-1.70609071344954	0.00530166255312299	M2_vs_M1	HSALNG0146662	integenic	Not conserved	NA	NA	NFE2L2	ENSG00000289351
ENSG00000229400	CNIH3-AS1	-4.69991098633806	1.81053286149633e-13	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	TEAD2
ENSG00000229484	LINC02766	2.17907714366238	9.64761970435185e-5	M2_vs_M1	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	FOLR1
ENSG00000229525	DNPEP-AS1	4.78935866685111	0.0462927208829117	M2_vs_M1	HSALNG0022376	anti_sense,sense	Q50	NA	-	DES	TLCD2
ENSG00000229664	NA	-5.6152705482733	0.003918309902341	M2_vs_M1	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17	DKK3
ENSG00000229771	NA	3.09110625728497	6.59754793715179e-63	M2_vs_M1	HSALNG0130126	integenic	Q90	NA	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement	MAFB	CD37
ENSG00000229922	LINC02865	-5.52011787250755	0.0117268342905674	M2_vs_M1	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	ENSG00000232680
ENSG00000229931	ATXN1-AS1	1.992534738735	4.704277948272941e-9	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	SMIM13
ENSG00000229953	BCAN-AS2	1.23034955976187	0.015244338688898	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	LAMC1
ENSG00000230061	TRPM2-AS	-1.85976797323452	0.0166041612539016	M2_vs_M1	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	NABP1
ENSG00000230107	NA	-2.69499139253399	9.60957514069435e-8	M2_vs_M1	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	TMEM176A
ENSG00000230303	NA	2.53330200780947	0.03413056146839	M2_vs_M1	HSALNG0072359	integenic	Not conserved	NA	Viral load,-	AGTPBP1	ENSG00000286787
ENSG00000230438	SERPINB9P1	-1.85276958738617	1.74209213448087e-50	M2_vs_M1	HSALNG0047525	integenic	Not conserved	NA	NA	SERPINB9	CYBC1
ENSG00000230479	NA	2.09430962498399	0.00918834273333088	M2_vs_M1	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	FARSB
ENSG00000230487	PSMG3-AS1	1.21217836587625	2.30877219849256e-15	M2_vs_M1	HSALNG0055664	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-762,hsa-miR-1268b,hsa-miR-5589-5p,hsa-miR-6089	-	MAFK	LINC02685
ENSG00000230537	LINC02937	5.1871783510672	0.0129409127579033	M2_vs_M1	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	KCNH3
ENSG00000230555	LINC02916	1.08256035713884	0.0154368627686275	M2_vs_M1	HSALNG0077549	integenic	Q50	hsa-miR-619-5p	NA	ZNF487	VAV2
ENSG00000230647	NA	-8.02441029110778	3.76416350702847e-14	M2_vs_M1	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	ENSG00000230647
ENSG00000230747	NA	2.57389207371439	1.4711647169356402e-9	M2_vs_M1	HSALNG0017036	sense	Not conserved	NA	Hemoglobin a1 measurement; Unipolar depression,-	SNRNP200	ENSG00000272768
ENSG00000230825	LINC03016	-4.73450452518988	0.0485656181779714	M2_vs_M1	HSALNG0056038	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290	Smooth surface dental caries,Daytime rest measurement,Body mass index; Visceral adipose tissue measurement	C1GALT1	LINC02068
ENSG00000230838	LINC01614	5.2013152655774	1.2512840206667499e-45	M2_vs_M1	HSALNG0022084	integenic	Q50	NA	Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169	TBCK
ENSG00000230943	LINC02541	-2.38200354980498	1.95579912927945e-10	M2_vs_M1	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	ICMT
ENSG00000231131	LNCAROD	-3.0483112644435	1.27350791011001e-8	M2_vs_M1	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	CYB5R4
ENSG00000231233	CFAP58-DT	-1.26239987061179	6.73427495400002e-4	M2_vs_M1	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	F5
ENSG00000231346	LINC01160	3.2776963831631	6.03073017587417e-50	M2_vs_M1	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	MAP1S
ENSG00000231528	FAM225A	-3.67476124338706	1.81523600489751e-32	M2_vs_M1	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	FICD
ENSG00000231574	LINC02015	-3.97729753689537	8.33807823268577e-9	M2_vs_M1	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	LINC00472
ENSG00000231663	COA6-AS1	1.8303030684055	0.0324407890233589	M2_vs_M1	HSALNG0011591	anti_sense	Q50	hsa-miR-6763-5p	-	TARBP1	SLC25A5-AS1
ENSG00000231672	DIRC3	1.80773596387256	4.48607111206667e-6	M2_vs_M1	HSALNG0022200	integenic	Not conserved	NA	NA	TNS1	SDCBP
ENSG00000231808	LINC01388	-1.48456205536734	6.16776863374846e-4	M2_vs_M1	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	H2BC8
ENSG00000231856	NA	-2.19996809997551	0.0347103409288629	M2_vs_M1	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2	PALMD
ENSG00000231858	STAT4-AS1	-6.77997665968431	5.42988610625849e-7	M2_vs_M1	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS	HLA-DOB
ENSG00000232053	NA	-1.00865729966646	0.00835110305113105	M2_vs_M1	HSALNG0061598	integenic	Q75	hsa-miR-663b	NA	STMP1	FUT8
ENSG00000232093	DCST1-AS1	1.78599708520905	0.0226793333940229	M2_vs_M1	HSALNG0007463	anti_sense	Q50	hsa-miR-1207-5p	Calcium measurement; Serum urea measurement; Serum albumin measurement,Hba1c measurement,Dna methylation,Serum gamma-glutamyl transferase measurement; Urate measurement,Forehead morphology measurement,Bmi-adjusted hip circumference,Blood protein measurement; Smoking status measurement,Skin neoplasm,Gait measurement,Eosinophil percentage of leukocytes,Varicose veins; Chin morphology measurement; Cortical surface area measurement; Mosquito bite reaction size measurement; Facial morphology measurement; Serum albumin measurement; Risk-taking behaviour,Attention deficit hyperactivity disorder; Systemic lupus erythematosus; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,-	DCST2	TRPV5
ENSG00000232160	RAP2C-AS1	-1.27931589373695	0.0132153508250746	M2_vs_M1	HSALNG0140185	integenic	Not conserved	NA	NA	STK26	UBE2FP1
ENSG00000232295	NA	-1.00516791663253	0.0333844016386928	M2_vs_M1	HSALNG0051162	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Antipsychotic drug related weight gain; Longitudinal bmi measurement,Beta-amyloid 1-42 measurement,Heel bone mineral density,Lung carcinoma,Body height,-	B3GAT2	ENSG00000291064
ENSG00000232310	LINC03002	2.41124708869674	0.00100637837647538	M2_vs_M1	HSALNG0053635	integenic	Q75	hsa-miR-6838-5p	NA	SGK1	DCAF1
ENSG00000232453	LINC02777	1.0473714718903	1.8843379184598702e-10	M2_vs_M1	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	RBM7
ENSG00000232485	RPL37A-DT	1.44826973555619	2.61927160850032e-5	M2_vs_M1	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	HLA-DPA3
ENSG00000232545	NA	-1.49187937870093	0.00590817056243631	M2_vs_M1	HSALNG0134472	sense	Q90	hsa-miR-4529-5p,hsa-miR-6132	NA	CABIN1	NDRG2
ENSG00000232618	HIVEP2-DT	-6.55331093323701	2.7027195410209e-5	M2_vs_M1	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	HIVEP2-DT
ENSG00000232656	IDI2-AS1	-1.0869344260046	0.0055822890581814	M2_vs_M1	HSALNG0075528	anti_sense	Q75	hsa-miR-3940-5p,hsa-miR-4433a-3p	Response to candesartan,-	GTPBP4	C8orf76
ENSG00000232680	NA	-5.52013251073155	0.0119502963283062	M2_vs_M1	HSALNG0125614	integenic	Not conserved	NA	NA	KRTDAP	ENSG00000232680
ENSG00000232912	RERE-AS1	-2.98507111227205	5.10319074771197e-8	M2_vs_M1	HSALNG0000636	anti_sense	Q50	hsa-miR-920,hsa-miR-4447,hsa-miR-4505	Self reported educational attainment,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Thyroid peroxidase antibody measurement; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Diastolic blood pressure; Depressive symptom measurement; Basophil count; Unipolar depression; Smoking status measurement; Eosinophil count; Vitiligo,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Tourette syndrome; Aspartate aminotransferase measurement,Body fat percentage,Cup-to-disc ratio measurement; Systolic blood pressure,Open-angle glaucoma,Autism spectrum disorder,Self reported educational attainment; Intelligence,Wellbeing measurement,-	SLC45A1	ACAP3
ENSG00000232956	SNHG15	-1.47077141000284	9.048557694403719e-31	M2_vs_M1	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	AFTPH-DT
ENSG00000233029	NA	-5.70739772710136	0.00272389659644309	M2_vs_M1	HSALNG0142289	anti_sense	Not conserved	NA	-	FAM72B	ENSG00000254287
ENSG00000233030	NA	-7.52005782387802	2.18100074105445e-11	M2_vs_M1	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	TFAP2C
ENSG00000233077	LINC01271	-2.31995018488794	1.71494597563707e-7	M2_vs_M1	HSALNG0130754	integenic	Q50	hsa-miR-6875-3p	Thyroid stimulating hormone measurement,Monocyte count,-	PEDS1	FOXRED1
ENSG00000233175	FMNL1-AS1	-2.54746704109856	0.0373248560526228	M2_vs_M1	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32	STEAP4
ENSG00000233237	LINC00472	-4.02372882848537	2.3353068122410297e-16	M2_vs_M1	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	LINC02015
ENSG00000233251	NA	5.02414600064562	0.0261157235429842	M2_vs_M1	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ASCL1
ENSG00000233360	PDXP-DT	-1.80704098517092	0.025273830230087	M2_vs_M1	HSALNG0135333	anti_sense	Q75	hsa-miR-6749-3p	-	LGALS2	EIF3B
ENSG00000233384	CNIH3-AS2	2.03613148316995	1.37563741164324e-10	M2_vs_M1	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	MKLN1
ENSG00000233392	UICLM	7.9845719777118	2.23986053807924e-15	M2_vs_M1	HSALNG0023633	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-4492,hsa-miR-6791-5p	NA	MAB21L4	ENSG00000286584
ENSG00000233559	LINC00513	1.75601151326905	0.00124450874223009	M2_vs_M1	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	JDP2-AS1
ENSG00000233610	LINC00462	-5.1787856996403	0.0151970047848826	M2_vs_M1	HSALNG0097004	anti_sense	Not conserved	NA	NA	RCBTB2	SEC63
ENSG00000233613	DCUN1D2-AS	2.74329260780001	0.033953736869279	M2_vs_M1	HSALNG0099596	anti_sense	Not conserved	NA	Neutrophil count; Monocyte percentage of leukocytes,-	TMCO3	PAXIP1-DT
ENSG00000233621	ZC3H12A-DT	-1.50643951382574	7.33618395421094e-32	M2_vs_M1	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	PRMT5
ENSG00000233785	NA	-2.38406485006193	0.00129724556795522	M2_vs_M1	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9	ENSG00000267074
ENSG00000233818	CLDN14-AS1	2.76624659762159	6.46543883506571e-8	M2_vs_M1	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	LGALS8
ENSG00000233901	LINC01503	2.03186721359922	7.181742001860139e-19	M2_vs_M1	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA	RTP4
ENSG00000233975	LINC02574	-5.9499246132306	9.48384210052635e-4	M2_vs_M1	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	LINC02574
ENSG00000234142	LINC01675	-5.87400371285466	5.01442746766187e-4	M2_vs_M1	HSALNG0008185	integenic	Q75	NA	-	FAM78B	LINC01597
ENSG00000234147	NA	3.58147573201071	2.9335306902085e-8	M2_vs_M1	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	SYVN1
ENSG00000234177	LINC01114	4.03499724044205	6.55790171993468e-4	M2_vs_M1	HSALNG0017537	anti_sense	Q90	hsa-miR-328-3p,hsa-miR-3196,hsa-miR-8485	Chronotype measurement,Pancreatic carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Body weight,Mean arterial pressure,Lifestyle measurement; Neuroimaging measurement; Body mass index; Brain measurement; Body height,Brain volume measurement,-	TGFBRAP1	FBXO16
ENSG00000234211	NA	4.99199538870859	0.0173789820605206	M2_vs_M1	HSALNG0007963	anti_sense	Q75	NA	Rheumatoid arthritis,Aspartate aminotransferase measurement,Erythrocyte count,Monocyte percentage of leukocytes,-	FCGR3B	DUOX2
ENSG00000234327	ZNF232-AS1	1.28424450572772	0.00140541352934627	M2_vs_M1	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3	RN7SL23P
ENSG00000234389	NA	-6.77964537673943	1.0942624793503e-6	M2_vs_M1	HSALNG0017421	sense	Not conserved	hsa-miR-6811-3p	NA	IL18RAP	GADD45B
ENSG00000234394	LINC03025	-7.08125047383203	6.55740406002769e-7	M2_vs_M1	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5	SAA1
ENSG00000234432	LINC02983	3.35108164283195	2.90853713544781e-5	M2_vs_M1	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	HHATL
ENSG00000234456	MAGI2-AS3	-2.79351881864081	1.10421871590356e-48	M2_vs_M1	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	C1QA
ENSG00000234506	LINC01506	1.32970106805242	0.0228322639190115	M2_vs_M1	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	TRAF6
ENSG00000234572	LINC01800	3.81854007789735	8.0814209066242e-29	M2_vs_M1	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2	WDR55
ENSG00000234630	NA	2.23321301572511	0.0210596264877029	M2_vs_M1	HSALNG0134317	integenic	Not conserved	hsa-miR-874-3p,hsa-miR-6775-3p	NA	VPREB1	VRK1
ENSG00000234807	LINC01135	3.67078938937115	5.423305927820579e-136	M2_vs_M1	HSALNG0003956	anti_sense	Q50	hsa-miR-497-5p,hsa-miR-504-3p,hsa-miR-922,hsa-miR-3197,hsa-miR-5587-3p,hsa-miR-5787,hsa-miR-6722-3p,hsa-miR-6728-3p,hsa-miR-6829-3p,hsa-miR-6873-3p,hsa-miR-7108-3p	Aminoadipic acid measurement,Neuropsychological test,Empathy measurement,Sleep duration,-	FGGY	CRYZ
ENSG00000234869	LINC02925	2.170571408957	1.41777159198397e-5	M2_vs_M1	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	ENSG00000287893
ENSG00000234883	MIR155HG	-1.73850094066772	2.17911018874523e-27	M2_vs_M1	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	ENSG00000202533
ENSG00000234919	LINC01827	3.23590957678893	1.93716699164423e-7	M2_vs_M1	HSALNG0021276	anti_sense	Q50	hsa-miR-4463,hsa-miR-6825-5p,hsa-miR-1273h-5p	Neuroticism measurement; Temperament and character inventory,Intelligence,Ankle injury,Food allergy measurement,Response to benznidazole,Eye colour measurement,Gut microbiome measurement,Parental longevity,Proliferative diabetic retinopathy,Blood urea nitrogen measurement,Abnormality of chromosome segregation,Interleukin 2 measurement,Lymphoid leukemia,Bipolar disorder; Attention deficit hyperactivity disorder,Response to thiopurine; Leukopenia,Response to antimicrotubule agent; Response to antineoplastic agent,-	DNAH7	RBM12B
ENSG00000235215	NA	-3.12893688061035	0.0148173668167514	M2_vs_M1	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	MRPL50
ENSG00000235257	ITGA9-AS1	3.44354327375644	4.38737527025496e-5	M2_vs_M1	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	KLHL12
ENSG00000235314	LINC00957	1.11157751737509	1.86047751791493e-4	M2_vs_M1	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL	KIF5C
ENSG00000235381	NA	1.30405457312436	0.0158659842225457	M2_vs_M1	HSALNG0054500	anti_sense,sense	Q90	NA	-	TFB1M	OIP5-AS1
ENSG00000235407	CYMP-AS1	4.75172718152147	0.031823375627843	M2_vs_M1	HSALNG0005984	integenic	Not conserved	NA	-	KCNA10	CYMP-AS1
ENSG00000235478	LINC01664	4.30780589126138	2.03467765803838e-4	M2_vs_M1	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	H2BC26
ENSG00000235513	L3MBTL2-AS1	-3.34212663914056	7.549929723228159e-31	M2_vs_M1	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	SIX5
ENSG00000235531	MSC-AS1	-1.94918953911902	5.8616513223610995e-43	M2_vs_M1	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	ZSCAN25
ENSG00000235545	DOCK7-DT	4.06259721615947	1.55510770762502e-4	M2_vs_M1	HSALNG0004080	anti_sense	Q50	NA	Serum metabolite measurement,High density lipoprotein cholesterol measurement,Platelet count,Triglyceride measurement,Mean corpuscular volume,Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Blood metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Bilirubin measurement,-	ATG4C	NUDT4
ENSG00000235641	LINC00484	4.84196402021286	0.0401687784089927	M2_vs_M1	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	LINC00484
ENSG00000235703	EOLA2-DT	1.13080266896575	3.00708046867182e-6	M2_vs_M1	HSALNG0140629	integenic	Q50	hsa-miR-4640-3p	NA	HSFX4	RICTOR
ENSG00000235770	LINC00607	1.99088858943255	4.264555676475951e-9	M2_vs_M1	HSALNG0022091	integenic	Not conserved	NA	-	MREG	TAOK2
ENSG00000235823	OLMALINC	-1.1276466233046	3.07432066726245e-6	M2_vs_M1	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	SEPHS2
ENSG00000235910	APOA1-AS	-2.55003109813236	0.0138740672715229	M2_vs_M1	HSALNG0087417	anti_sense	Not conserved	NA	Blood protein measurement,High density lipoprotein cholesterol measurement,Sleep duration; Triglyceride measurement,Serum metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; High density lipoprotein cholesterol measurement,-	APOC3	MKNK2
ENSG00000235979	NA	5.51598661968459	0.00585740025205862	M2_vs_M1	HSALNG0115130	integenic	Not conserved	NA	NA	MFAP4	PRDM5
ENSG00000236404	VLDLR-AS1	4.78909150403974	0.0335325635263987	M2_vs_M1	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	EIF4BP9
ENSG00000236700	LINC01010	1.49154965753633	4.31003452829422e-70	M2_vs_M1	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	CEP135
ENSG00000236790	LINC00299	-5.79246409325809	0.00165614952626399	M2_vs_M1	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	NASP
ENSG00000236841	NA	3.3820389495545	0.0145922847237813	M2_vs_M1	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	PLEK2
ENSG00000236846	NA	6.01344390227889	8.6355659631647e-4	M2_vs_M1	HSALNG0010877	integenic	Q50	hsa-miR-22-3p,hsa-miR-3192-5p,hsa-miR-4472,hsa-miR-6780a-3p	NA	DISP1	TIMMDC1-DT
ENSG00000236901	MIR600HG	1.04448433123777	3.75338309850997e-10	M2_vs_M1	HSALNG0074272	sense	Not conserved	NA	-	STRBP	ENSG00000279278
ENSG00000236914	LINC01852	-3.21576445868804	0.011309778242243	M2_vs_M1	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1	ANKUB1
ENSG00000236939	BAALC-AS2	-3.30074386011184	4.3786696535018e-35	M2_vs_M1	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	ENSG00000288954
ENSG00000237248	LINC00987	-2.47682852281324	0.0442810456456191	M2_vs_M1	HSALNG0089130	integenic	Q50	hsa-miR-619-5p,hsa-miR-6769b-5p	-	KLRG1	ENSG00000280353
ENSG00000237310	LINC03011	1.01750420096241	0.0173003304267875	M2_vs_M1	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	HEATR3
ENSG00000237352	LINC01358	-3.87903777099298	9.0863295807103e-27	M2_vs_M1	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	CSF3
ENSG00000237372	NA	-4.22846987802657	1.09924929078568e-30	M2_vs_M1	HSALNG0072619	integenic	Not conserved	NA	NA	GADD45G	PMEPA1
ENSG00000237499	WAKMAR2	-2.35804044305272	1.35897592866281e-10	M2_vs_M1	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	ENSG00000290041
ENSG00000237525	NA	5.42985549294002	1.688535639693e-23	M2_vs_M1	HSALNG0022085	integenic	Q50	NA	-	ATIC	ENSG00000272942
ENSG00000237638	LINC02245	1.78164194931555	1.07138057010493e-22	M2_vs_M1	HSALNG0015516	integenic	Not conserved	NA	NA	RAB1A	TMTC4
ENSG00000237886	NALT1	1.97845927167025	0.0136903537404397	M2_vs_M1	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7	PRR19
ENSG00000237927	NA	-3.98743655261608	4.12264938382478e-5	M2_vs_M1	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	EPB41L5
ENSG00000237943	PRKCQ-AS1	-1.36765330659558	0.0120122151556136	M2_vs_M1	HSALNG0075966	integenic	Q50	hsa-miR-30b-3p,hsa-miR-891a-3p,hsa-miR-4632-3p,hsa-miR-6763-5p	Atopic asthma,Eosinophil count,Eczema; Respiratory system disease,Eosinophil percentage of leukocytes,Eczema; Allergic rhinitis,-	PFKFB3	CUTALP
ENSG00000237976	RFX5-AS1	-1.86314941240915	0.0394942142223852	M2_vs_M1	HSALNG0007143	anti_sense	Q90	NA	-	PSMB4	AGK
ENSG00000237989	LINC01679	-3.29097097277468	0.00653035453996539	M2_vs_M1	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1	ENSG00000270605
ENSG00000238045	MVP-DT	-2.74144726411709	6.65468984802948e-34	M2_vs_M1	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	CEBPB
ENSG00000238164	TNFRSF14-AS1	1.29299907514895	9.191495768235349e-40	M2_vs_M1	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	ALDH3B1
ENSG00000239445	ST3GAL6-AS1	1.78979322678117	1.76266699575764e-35	M2_vs_M1	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2	TNFRSF14-AS1
ENSG00000240057	NEPRO-AS1	-1.41927834218881	0.019711458824278	M2_vs_M1	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	GYG1P3
ENSG00000241042	NA	-5.17930302002302	0.0261890271425701	M2_vs_M1	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	ENSG00000241042
ENSG00000241886	NA	-1.50605955204487	3.877977967392e-6	M2_vs_M1	HSALNG0137207	sense	Q90	NA	-	GK	PLSCR2
ENSG00000242048	PRKAG2-AS2	-2.77198377646367	1.27446106076448e-67	M2_vs_M1	HSALNG0149841	anti_sense	Not conserved	NA	NA	GALNTL5	SPRED3
ENSG00000242258	LINC00996	-8.6139605082838	2.50426890652358e-21	M2_vs_M1	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	B3GALNT1
ENSG00000242516	LINC00960	-2.72954324649283	3.1765699798305e-7	M2_vs_M1	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	KL
ENSG00000242973	TDRD6-AS1	-3.43232547654147	0.00247320011021758	M2_vs_M1	HSALNG0050369	anti_sense	Q50	hsa-miR-567,hsa-miR-4447	Hashimoto's thyroiditis; Autoimmune thyroid disease; Graves disease,-	PLA2G7	ADORA3
ENSG00000243055	GK-AS1	-1.98568852255927	4.676257305788281e-15	M2_vs_M1	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	MARCHF3
ENSG00000243089	NA	-3.92588252224515	2.43478842292878e-8	M2_vs_M1	HSALNG0027523	integenic	Q50	NA	Bmi-adjusted waist circumference; Optic cup area measurement,Serum alanine aminotransferase measurement,Precuneus cortex volume measurement,Optic cup area measurement; Optic disc size measurement,Cup-to-disc ratio measurement,Rr interval,Optic disc area measurement,Liver fibrosis measurement,Susceptibility to childhood ear infection measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Chronic kidney disease,Body height,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Cup-to-disc ratio measurement; Optic cup area measurement,-	FILIP1L	SRSF12
ENSG00000243491	NA	3.79146318576676	8.99136337326438e-6	M2_vs_M1	HSALNG0012921	integenic	Not conserved	hsa-miR-665,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6829-5p	NA	YWHAQ	CDC14B
ENSG00000244586	WNT5A-AS1	-6.39603902764128	1.49039309099995e-4	M2_vs_M1	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	LINC03032
ENSG00000245025	NA	-1.45741538471796	8.82082200213076e-6	M2_vs_M1	HSALNG0063952	anti_sense	Not conserved	hsa-miR-6805-5p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Renal cell carcinoma,Basal cell carcinoma,-	PEBP4	CD99L2
ENSG00000245248	USP2-AS1	2.63584786725577	3.5606272447170804e-21	M2_vs_M1	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	DGKZ
ENSG00000245552	LNCRNA-IUR	-3.01309063798699	8.4286776439434e-7	M2_vs_M1	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1	LINC02846
ENSG00000245573	BDNF-AS	1.57996835304241	1.22681516384859e-5	M2_vs_M1	HSALNG0083312	integenic	Not conserved	NA	NA	BBOX1	ARV1
ENSG00000245928	SDAD1-AS1	-6.93877294058311	5.40598918959174e-7	M2_vs_M1	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	G0S2
ENSG00000246250	NA	-1.65230785424831	0.0353630190489473	M2_vs_M1	HSALNG0083840	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4487	Body mass index,Chronotype measurement,-	ALX4	C1orf35
ENSG00000246528	SLCO5A1-AS1	-5.61548446353359	0.00432436335028649	M2_vs_M1	HSALNG0066029	anti_sense	Q50	NA	Leukocyte count; Neutrophil count,Diverticular disease,Response to cetuximab; Skin disease,-	SULF1	NBDY
ENSG00000246640	PICART1	2.74214337668398	6.49667582811151e-6	M2_vs_M1	HSALNG0117242	anti_sense	Q90	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-10392-3p	-	SAMD14	LHFPL5
ENSG00000247081	BAALC-AS1	-2.8581629158619	1.14367849339919e-5	M2_vs_M1	HSALNG0067506	integenic	Q50	NA	NA	SLC25A32	SPRN
ENSG00000247095	MIR210HG	-3.23285074467995	8.320111260619e-5	M2_vs_M1	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	PUS7
ENSG00000247317	LY6E-DT	-3.48283468312801	0.00775699247680755	M2_vs_M1	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	HNRNPA3
ENSG00000247708	STX18-AS1	1.10026289660518	3.0176104240248804e-15	M2_vs_M1	HSALNG0032553	integenic	Q50	NA	NA	MSX1	GIMAP7
ENSG00000248187	NA	4.24355620551881	1.28122796812851e-200	M2_vs_M1	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	TBC1D8
ENSG00000248323	LUCAT1	-1.27595970766019	1.1172452183751e-14	M2_vs_M1	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3	ARF6
ENSG00000248538	PPP1R3B-DT	5.2793319714703	0.0288449566789071	M2_vs_M1	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	THSD7A
ENSG00000248693	LINC02100	-3.21576863367609	0.0113146096626176	M2_vs_M1	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	ENSG00000270966
ENSG00000248809	LINC01095	-5.30047457304853	0.01866752683458	M2_vs_M1	HSALNG0037693	integenic	Q50	hsa-miR-1227-5p,hsa-miR-6802-5p,hsa-miR-6819-5p,hsa-miR-1273h-5p	Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio; Response to bronchodilator,-	SLC10A7	DKK3
ENSG00000248932	COPB2-DT	1.29928059545642	4.85495030978423e-5	M2_vs_M1	HSALNG0029337	integenic	Not conserved	hsa-miR-765	NA	MRPS22	PLCB4
ENSG00000249173	LINC01093	-5.93809033507271	5.87294061067256e-18	M2_vs_M1	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	LINC01882
ENSG00000249207	NA	-2.61611275060472	0.0099610019285428	M2_vs_M1	HSALNG0033933	integenic	Not conserved	hsa-miR-6090,hsa-miR-1273h-5p	NA	TMEM156	HOMER1
ENSG00000249249	TICAM2-AS1	-3.47132700426461	9.54368422040204e-6	M2_vs_M1	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	ZBTB10
ENSG00000249502	MED28-DT	-2.83907418685111	2.1972800390824698e-33	M2_vs_M1	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	RHBDD1
ENSG00000249685	NA	-1.6500094792081	3.05310110515322e-4	M2_vs_M1	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	CCZ1B
ENSG00000249825	THBS4-AS1	3.4508010482911202	1.85810223999126e-15	M2_vs_M1	HSALNG0042960	anti_sense	Q90	hsa-miR-4447	Corneal topography,Intraocular pressure measurement,-,Thyroid stimulating hormone measurement; Abnormality of refraction	SERINC5	CCDC6
ENSG00000250033	SLC7A11-AS1	-4.36992693946577	1.7592613311569e-4	M2_vs_M1	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	ARHGEF10
ENSG00000250041	NA	2.62481979667365	9.71532920054156e-29	M2_vs_M1	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	PCBD1
ENSG00000250274	NA	-4.28203647070436	1.71583300377923e-14	M2_vs_M1	NA	NA	NA	NA	NA	LCP2	STING1
ENSG00000250519	NA	-2.67434866022249	2.00731342950557e-6	M2_vs_M1	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	CYBA
ENSG00000250548	LINC01303	-3.00612899580048	2.56057580771755e-8	M2_vs_M1	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	KIF1B
ENSG00000250777	NA	1.6983324739243	0.00280290492691398	M2_vs_M1	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	PGF
ENSG00000250802	ZBED3-AS1	2.72716758364431	2.57861184597537e-28	M2_vs_M1	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA	ENTPD4
ENSG00000250929	LINC01181	-3.0298446576653	9.092008147857389e-60	M2_vs_M1	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	TMEM140
ENSG00000251136	RIPK2-DT	-2.72828900933087	4.43224231976081e-112	M2_vs_M1	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	ZNFX1
ENSG00000251179	TMEM92-AS1	-5.87400248185875	4.28748700709547e-4	M2_vs_M1	HSALNG0117279	anti_sense	Not conserved	hsa-miR-762,hsa-miR-4505,hsa-miR-6813-5p	NA	COL1A1	CCR6
ENSG00000251230	MIR3945HG	-5.95444883635649	4.65492371981892e-177	M2_vs_M1	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	GBP1P1
ENSG00000251301	LINC02384	-6.84630306793291	4.051910612452899e-236	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	WARS1
ENSG00000251323	LINC02728	-3.15869414739566	1.18758656516903e-7	M2_vs_M1	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2	KCNK5
ENSG00000251432	LINC02615	1.34425275529799	0.032096480437252	M2_vs_M1	HSALNG0037069	integenic	Q50	NA	NA	LARP1B	MIR1286
ENSG00000251586	TET2-AS1	1.99084897885405	0.0197870158765126	M2_vs_M1	HSALNG0036166	anti_sense	Not conserved	NA	Ulcerative colitis; Intelligence; Body height,Intelligence; Testosterone measurement; Insomnia measurement; Body height; Body weight,Bmi-adjusted waist circumference; Glomerular filtration rate,Heel bone mineral density,Uric acid measurement,Leukocyte count,Forced expiratory volume,Pulse pressure measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Intelligence,Body height,Lifestyle measurement,Colorectal cancer; Household income; Colorectal adenoma,Forced expiratory volume; Chronic obstructive pulmonary disease,Trauma exposure measurement; Primary biliary cirrhosis,Fev/fec ratio; Primary biliary cirrhosis,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte percentage of leukocytes; Glomerular filtration rate; Lymphocyte count; Creatinine measurement; Neutrophil percentage of leukocytes,Neutrophil count,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Self reported educational attainment; Intelligence; Risk-taking behaviour; Hemorrhoid,Melanoma,Self reported educational attainment; Intelligence; Mathematical ability,Self reported educational attainment; Intelligence; Birth weight,Age at menarche,Tonsillectomy risk measurement,Attention deficit hyperactivity disorder; Risk-taking behaviour; Antisocial behaviour measurement; Substance abuse,Intelligence; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Self reported educational attainment,Appendicular lean mass,Platelet count,Prostate carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Risky sexual behaviour measurement,Intelligence; Risk-taking behaviour,Platelet crit,Breast carcinoma,Self reported educational attainment; Intelligence; Mathematical ability; Coffee consumption measurement; Cognitive function measurement,Intelligence; Household income,Intelligence; Lean body mass,Body weight,Neutrophil-to-lymphocyte ratio; Total blood protein measurement; Intelligence; Lymphocyte count,Health study participation,Verbal-numerical reasoning measurement,Myeloid white cell count,Testosterone measurement,Response to vaccine,Household income,Social interaction measurement,Obesity,Wellbeing measurement,Bmi-adjusted hip circumference,Forced expiratory volume; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Nevus count; Cutaneous melanoma,Body height; Pulse pressure measurement; Chronic obstructive pulmonary disease,-,Forced expiratory volume; Birth weight; Chronic obstructive pulmonary disease; Fev/fec ratio; Peak expiratory flow; Smoking status measurement,Coffee consumption measurement; Tea consumption measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement; Bmi-adjusted waist-hip ratio,Serum non-albumin protein measurement	PPA2	SMIM17
ENSG00000253123	NA	1.3602915661334	4.45787681938179e-53	M2_vs_M1	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2	KCNK6
ENSG00000253154	NA	2.06178679235103	4.40141135614868e-7	M2_vs_M1	HSALNG0066721	integenic	Q50	hsa-miR-4463,hsa-miR-8485	Chronotype measurement,-	ATP6V0D2	B3GALNT2
ENSG00000253217	NA	1.32483454662434	0.0306005566418765	M2_vs_M1	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	MIA2-AS1
ENSG00000253317	NA	-5.41397119502022	0.00463791800251149	M2_vs_M1	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	DEFB1
ENSG00000253320	MAILR	-2.91373672179132	8.33213189470849e-32	M2_vs_M1	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	LINC01010
ENSG00000253351	LINC01298	7.87674036621523	4.84482681664535e-16	M2_vs_M1	HSALNG0067084	integenic	Q50	hsa-miR-30b-3p,hsa-miR-331-3p,hsa-miR-4308,hsa-miR-5572	Low density lipoprotein cholesterol measurement	CFAP418	ENSG00000259871
ENSG00000253522	MIR3142HG	-1.71412044025042	7.233733377983459e-118	M2_vs_M1	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	PDCD6IP
ENSG00000253535	ADAM7-AS1	-4.75482717010789	3.17723607332412e-9	M2_vs_M1	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	PLEKHA2
ENSG00000253549	CA3-AS1	1.54780736474823	1.46490116467553e-4	M2_vs_M1	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	WBP11
ENSG00000253593	NA	-2.9549070986884	0.0268305355554882	M2_vs_M1	HSALNG0068775	integenic	Not conserved	hsa-miR-6873-3p	Response to alcohol	CCN4	ENSG00000256894
ENSG00000253671	NA	1.124128061338	1.42875712436236e-4	M2_vs_M1	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	DYNLT2
ENSG00000253738	OTUD6B-AS1	1.06232345223688	8.482800329324121e-14	M2_vs_M1	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	MB21D2
ENSG00000253773	CFAP418-AS1	3.60347163431957	1.35734965314146e-23	M2_vs_M1	HSALNG0150259	integenic	Q50	hsa-miR-3960,hsa-miR-6089,hsa-miR-8072	NA	PLEKHF2	CRB2
ENSG00000253837	NA	-2.40782290976825	0.0287988596891335	M2_vs_M1	HSALNG0063981	anti_sense	Q50	hsa-miR-4534	-	R3HCC1	DGAT1
ENSG00000253838	NA	-7.97541455186548	1.6833584575609e-78	M2_vs_M1	HSALNG0150187	sense	Q50	NA	-	IDO1	CCM2L
ENSG00000253891	NA	-6.86190967372786	1.24770040667615e-6	M2_vs_M1	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	RFX2
ENSG00000253924	NA	4.84022712666238	0.0383979777814308	M2_vs_M1	HSALNG0065257	anti_sense	Q90	NA	NA	NPBWR1	RPH3AL-AS1
ENSG00000253931	LINC02990	3.98063697947805	1.7207697106476698e-11	M2_vs_M1	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	CKAP5
ENSG00000253939	NA	-5.30135306975163	0.00760260549922768	M2_vs_M1	HSALNG0064732	anti_sense	Q50	NA	Blood metabolite measurement	ADAM2	NAV3
ENSG00000254027	LNMICC	1.64906005519464	4.53928008354014e-6	M2_vs_M1	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	SLCO2B1
ENSG00000254054	NA	6.0918571262026	1.37815251746358e-16	M2_vs_M1	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	GPRC5C
ENSG00000254233	LINC02365	1.33612710443721	0.0113389805996607	M2_vs_M1	HSALNG0039030	integenic	Not conserved	NA	NA	CASP3	PIGH
ENSG00000254248	NA	5.26206792658984	0.00338012045577536	M2_vs_M1	HSALNG0067071	anti_sense	Not conserved	hsa-miR-6763-5p	Serum alanine aminotransferase measurement,-	TP53INP1	UNC80
ENSG00000254254	PENK-AS1	-5.3010800384627	0.0105504421612197	M2_vs_M1	HSALNG0065478	integenic	Q75	hsa-miR-4296	NA	CHCHD7	NBDY
ENSG00000254287	NA	-10.115660792652	1.99656678092021e-49	M2_vs_M1	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	ENSG00000233029
ENSG00000254338	MAFA-AS1	4.63290374261158	6.31801748168355e-10	M2_vs_M1	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	PABIR2
ENSG00000254419	NA	1.11629351364906	0.00806956718126022	M2_vs_M1	HSALNG0131276	sense	Not conserved	NA	NA	NPEPL1	TMEM175
ENSG00000254545	NA	1.55207082287594	0.0401988910754129	M2_vs_M1	HSALNG0002264	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-4498	-	HCRTR1	MARCHF6
ENSG00000254554	ADM-DT	-3.8899956395389	1.01488023853056e-4	M2_vs_M1	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	PDIA4
ENSG00000254654	LINC02685	6.04754715462979	1.82689009388132e-4	M2_vs_M1	HSALNG0083903	integenic	Q50	hsa-miR-30b-3p	-	TSPAN18	SCT
ENSG00000254703	SENCR	1.8941410552497	8.53775289165236e-7	M2_vs_M1	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	KLHL28
ENSG00000254859	NA	-1.407635594258	0.00560548387770969	M2_vs_M1	HSALNG0150508	integenic	Not conserved	NA	Leukocyte count	ZC3H3	FAF1
ENSG00000254872	LINC02688	4.98395078435597	3.19543098959221e-7	M2_vs_M1	HSALNG0082072	integenic	Q50	hsa-miR-874-3p,hsa-miR-4463	NA	MUC2	CLPTM1
ENSG00000255026	NA	-2.25740947184246	0.00274724408788533	M2_vs_M1	HSALNG0081949	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-766-3p	NA	PGGHG	CERK
ENSG00000255050	NA	-2.13482487757317	0.0262969074043106	M2_vs_M1	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	IFFO1
ENSG00000255135	EMSY-DT	1.71200729448149	3.96131735829484e-4	M2_vs_M1	HSALNG0085855	anti_sense	Q90	hsa-miR-30c-2-3p,hsa-miR-619-5p	Microglial activation measurement,-	THAP12	ZDHHC20P4
ENSG00000255197	NA	1.99878658715091	2.16711393565787e-58	M2_vs_M1	HSALNG0143174	anti_sense	Q90	NA	Alcohol consumption measurement	SPI1	PHKA2
ENSG00000255320	NA	1.22112745555805	0.0164044106369452	M2_vs_M1	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	RAD51B
ENSG00000255363	LINC02757	-2.40353322299994	2.48546334966718e-5	M2_vs_M1	HSALNG0085868	integenic	Not conserved	hsa-miR-4710	NA	LRRC32	DGKA
ENSG00000255422	NA	2.36195401292368	6.43490534597516e-16	M2_vs_M1	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	MDK
ENSG00000255443	CD44-AS1	-2.25910771909687	1.91021083255642e-4	M2_vs_M1	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	FASLG
ENSG00000255521	CD44-DT	-2.73410002334724	2.65617095333864e-5	M2_vs_M1	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	ELL
ENSG00000255571	MIR9-3HG	-5.41322262398624	0.00924259365705321	M2_vs_M1	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	SH2D1A
ENSG00000255801	NA	-6.15924696299799	1.27361715231458e-4	M2_vs_M1	HSALNG0089073	integenic	Not conserved	NA	Takayasu arteritis,Response to radiation	CLEC4E	GTF2I
ENSG00000255874	PRECSIT	-1.37516224887472	5.1440499824879e-4	M2_vs_M1	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	ARMH3
ENSG00000255921	NA	-1.78448413945342	5.52735140308274e-7	M2_vs_M1	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	ELL2
ENSG00000256128	LINC00944	-2.13703678483059	0.025367897588802	M2_vs_M1	HSALNG0094965	integenic	Not conserved	NA	Peripheral arterial disease; Traffic air pollution measurement	DHX37	ENSG00000279672
ENSG00000256196	NA	-1.78066039623554	0.0468890251116551	M2_vs_M1	HSALNG0084483	anti_sense	Q50	hsa-miR-3155b	Blood protein measurement,-	PRPF19	SGSM3
ENSG00000256262	USP30-AS1	-2.82543972001639	1.82974708035037e-50	M2_vs_M1	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CLU
ENSG00000256442	NA	-4.89898963008355	0.0456587188366024	M2_vs_M1	HSALNG0089163	integenic	Not conserved	hsa-miR-6515-5p	NA	KLRB1	ENSG00000254094
ENSG00000256508	MRGPRF-AS1	3.33182525605467	5.556082314599019e-40	M2_vs_M1	HSALNG0085291	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4710,hsa-miR-6735-3p,hsa-miR-6792-5p,hsa-miR-6803-5p,hsa-miR-6808-5p,hsa-miR-7108-3p	Reticulocyte count,Hair colour measurement,Mosquito bite reaction size measurement,-	TPCN2	VAT1
ENSG00000256746	MADD-AS1	-1.98824002215738	1.70293835339458e-16	M2_vs_M1	HSALNG0084043	intronic_antisense	Q75	hsa-miR-6747-3p	NA	ACP2	RASSF1
ENSG00000256948	NA	-1.03902573380826	4.45817661120385e-4	M2_vs_M1	HSALNG0088445	anti_sense	Not conserved	hsa-miR-939-5p	Response to candesartan	SLC6A12	LINC01943
ENSG00000256967	NA	-3.64772155729766	4.03770000480633e-12	M2_vs_M1	HSALNG0088974	anti_sense	Q50	hsa-miR-146b-3p	-	RBP5	LINC02015
ENSG00000257027	NA	-1.47010053526327	4.61627753910615e-11	M2_vs_M1	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	FSD1
ENSG00000257127	CLLU1	-4.64505305601217	1.67677212994806e-7	M2_vs_M1	HSALNG0093062	anti_sense	Q50	NA	Methionine measurement,Sudden cardiac arrest,-	PLEKHG7	CWF19L2
ENSG00000257354	MIRLET7IHG	-1.44875942799401	9.48846656400045e-12	M2_vs_M1	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	ZFX
ENSG00000257514	NA	3.53919351873947	0.00560073019922116	M2_vs_M1	HSALNG0093518	anti_sense	Q50	NA	-	SYCP3	LINC00467
ENSG00000257588	AQP5-AS1	5.44078357160645	0.00515910724655451	M2_vs_M1	HSALNG0090990	anti_sense	Q50	NA	-	RACGAP1	ZNF117
ENSG00000258018	LINC02457	1.68601479013709	5.01225133598982e-10	M2_vs_M1	HSALNG0094325	integenic	Not conserved	NA	NA	MAP1LC3B2	OGA
ENSG00000258404	LINC02320	2.43659991284485	3.08289387080697e-4	M2_vs_M1	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	IGFL2
ENSG00000258441	LINC00641	-1.4719839583394	3.24591659514509e-16	M2_vs_M1	HSALNG0099873	integenic	Not conserved	NA	Bipolar disorder,-	HNRNPC	TANC1
ENSG00000258512	LINC00239	1.84253104731644	3.61863728797329e-4	M2_vs_M1	HSALNG0103853	integenic	Not conserved	hsa-miR-4447	NA	PPP2R5C	ENSG00000286485
ENSG00000258521	NA	-2.79289608607178	3.7174166206979896e-25	M2_vs_M1	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	MTTP
ENSG00000258583	LINC01500	6.11226733861448	4.3035467336541e-45	M2_vs_M1	HSALNG0101652	integenic	Not conserved	NA	NA	DACT1	ZNF789
ENSG00000258602	LINC01629	-2.56558219505049	1.63667778460231e-10	M2_vs_M1	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A	CNOT10
ENSG00000258689	LINC01269	3.45769426693878	3.86480611903921e-9	M2_vs_M1	HSALNG0102232	integenic	Q50	hsa-miR-4309,hsa-miR-4478	-	TTC9	ZNF329
ENSG00000258733	LINC02328	-2.0593326545476	2.22012080533638e-8	M2_vs_M1	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	MCTP2
ENSG00000258768	NA	2.19905892804727	0.00189719029433925	M2_vs_M1	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5	UIMC1
ENSG00000258791	LINC00520	1.65270021326027	8.93130234972272e-19	M2_vs_M1	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2	ABHD12
ENSG00000258810	NA	2.26004678973414	5.84627670154444e-5	M2_vs_M1	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p	NA	RNASE6	SNORD14A
ENSG00000258875	NA	-2.57607122753598	2.27300476306969e-5	M2_vs_M1	HSALNG0103182	anti_sense	Q50	hsa-miR-7155-5p	NA	DGLUCY	CAPRIN2
ENSG00000258919	NA	1.96084558301573	1.11892039241623e-5	M2_vs_M1	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	SYS1
ENSG00000259065	MIDEAS-AS1	2.12050593212134	0.0037352891701468	M2_vs_M1	HSALNG0102380	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4323,hsa-miR-3135b,hsa-miR-4472	-	PTGR2	ENSG00000261245
ENSG00000259094	NA	5.61828650284088	5.78669030363917e-4	M2_vs_M1	HSALNG0018295	anti_sense	Not conserved	NA	-	EN1	M1AP
ENSG00000259225	LINC02345	2.73265201564816	1.1201921760895401e-15	M2_vs_M1	HSALNG0105099	integenic	Not conserved	NA	NA	TMCO5A	METTL9
ENSG00000259321	NA	-2.26236168175748	0.00324265342156988	M2_vs_M1	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	CD99L2
ENSG00000259342	NA	-3.23757089695167	1.38215546852456e-13	M2_vs_M1	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM	MMP10
ENSG00000259354	NA	-4.2939649693706	2.76087048368872e-44	M2_vs_M1	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	SCARA3
ENSG00000259407	NA	-4.89901208988279	0.0467310956777726	M2_vs_M1	HSALNG0107883	anti_sense	Q90	hsa-miR-4492,hsa-miR-2467-3p,hsa-miR-7843-5p	Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Eosinophil count,Systolic blood pressure,Eosinophil count; Eosinophil percentage of leukocytes,Alkaline phosphatase measurement,Varicose veins,Idiopathic pulmonary fibrosis,-	KLHL25	KIAA1755
ENSG00000259540	NA	-4.8983271539744	0.0322907495463783	M2_vs_M1	HSALNG0108586	anti_sense	Not conserved	NA	-	ASB7	ENSG00000259540
ENSG00000259590	LINC02244	1.22701725844435	7.02368904551242e-39	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	HAGHL
ENSG00000259668	NA	-1.09201738510993	6.07273600572636e-8	M2_vs_M1	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	ARID2
ENSG00000259673	IQCH-AS1	1.23488634888723	2.31345537406763e-6	M2_vs_M1	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB	CCDC34
ENSG00000259720	NA	3.41474825305541	0.0239190248767515	M2_vs_M1	HSALNG0144346	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4430	NA	FAN1	ENSG00000286698
ENSG00000259760	NA	1.20622939986377	5.0375348752610296e-27	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	ACAT2
ENSG00000259805	NA	3.18844148634238	0.0295694750414778	M2_vs_M1	HSALNG0107722	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-619-5p	Bmi-adjusted hip circumference,Coronary artery disease,Chronic obstructive pulmonary disease,Mucocutaneous lymph node syndrome,Intelligence,Glomerular filtration rate,Basophil count; Basophil percentage of leukocytes,-	RAMAC	FAM131A
ENSG00000259871	NA	6.59636095875409	1.3558265737737e-6	M2_vs_M1	HSALNG0109998	sense	Not conserved	hsa-miR-8485	NA	CLEC19A	LINC01298
ENSG00000260077	NA	-1.17551595129386	1.15632746475459e-5	M2_vs_M1	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1	RGL2
ENSG00000260101	AFTPH-DT	1.44373924396737	3.2522995825588e-10	M2_vs_M1	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	SNHG15
ENSG00000260135	MMP2-AS1	-2.33775403183592	2.67897863676107e-26	M2_vs_M1	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	ABHD17C
ENSG00000260188	NA	4.13355572609752	4.03562642365138e-4	M2_vs_M1	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	LINC00205
ENSG00000260193	LINC02846	1.32499095767176	0.00241106351806088	M2_vs_M1	HSALNG0075219	integenic	Q50	hsa-miR-6858-3p	NA	TMEM250	LNCRNA-IUR
ENSG00000260219	CD2BP2-DT	1.37383563129083	3.7349719353122595e-30	M2_vs_M1	HSALNG0110725	anti_sense	Q50	hsa-miR-4534,hsa-miR-6775-3p	-	MYL11	CRYZ
ENSG00000260256	NA	-2.81803251786452	2.9351245231257604e-9	M2_vs_M1	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	PDIA3
ENSG00000260260	SNHG19	1.1100606766178	0.0213688991929114	M2_vs_M1	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	RALGAPB
ENSG00000260302	LINC01882	-5.79317700333549	0.00106240153729558	M2_vs_M1	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2	SCARA3
ENSG00000260351	NA	2.46186573927116	3.50878212623351e-5	M2_vs_M1	HSALNG0144425	integenic	Q75	NA	NA	TM6SF1	ENSG00000291063
ENSG00000260528	FAM157C	-3.46736926440428	3.62078597392689e-4	M2_vs_M1	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8	SHISAL1
ENSG00000260542	NA	2.25568115073504	0.0019012747615967	M2_vs_M1	HSALNG0131538	integenic	Not conserved	NA	NA	GATA5	PYHIN1
ENSG00000260565	ERVK13-1	1.02712665494699	2.34396538985953e-21	M2_vs_M1	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27	PRKX
ENSG00000260630	SNAI3-AS1	1.43014843574538	5.97390903079882e-10	M2_vs_M1	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	APH1A
ENSG00000260661	NA	-5.04509010199805	0.038557416168312	M2_vs_M1	HSALNG0144613	anti_sense	Q75	NA	Diastolic blood pressure,3-hydroxy-1-methylpropylmercapturic acid measurement,Self reported educational attainment,Susceptibility to chronic sinus infection measurement,Dna methylation,Seasonal gut microbiome measurement,Parahippocampal gyrus volume measurement,Smoking initiation,Oral cleft; Alcohol consumption measurement,Colorectal cancer; Diet measurement,Serum dimethylarginine measurement,-	FAM174B	BACH2
ENSG00000260711	NA	-2.94656309441322	0.0448885035002622	M2_vs_M1	HSALNG0103215	sense	Not conserved	NA	NA	CATSPERB	FITM1
ENSG00000260751	NA	-1.97028251595062	0.022539422780858	M2_vs_M1	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	GOSR1
ENSG00000260803	NA	2.42945185152082	8.79331677899506e-4	M2_vs_M1	HSALNG0144829	integenic	Q75	hsa-miR-4650-5p	-	POLR3K	HMCN1
ENSG00000260804	LINC01963	1.83930459473667	8.119470180555011e-9	M2_vs_M1	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	TM4SF19-DYNLT2B
ENSG00000260807	CEROX1	1.71844903511301	1.17308623753355e-13	M2_vs_M1	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	HGSNAT
ENSG00000260877	NA	-3.10195228005332	9.05448933355223e-16	M2_vs_M1	HSALNG0085333	integenic	Not conserved	hsa-miR-4308,hsa-miR-4447,hsa-miR-4492	NA	MYEOV	TRAF2
ENSG00000260898	ADPGK-AS1	1.38461142072513	7.349067841636259e-11	M2_vs_M1	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	ST3GAL6
ENSG00000260941	LINC00622	1.26734514898622	0.00858870713349344	M2_vs_M1	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	MSMO1
ENSG00000260943	LINC02555	-2.40784561808567	0.028864518857929	M2_vs_M1	HSALNG0090479	integenic	Q50	NA	Inflammatory bowel disease,Low density lipoprotein cholesterol measurement,Mean platelet volume; Platelet count,Bacteriemia,-	SLC2A13	RANBP9
ENSG00000260997	NA	-6.71908910909167	2.4107997100767199e-144	M2_vs_M1	NA	NA	NA	NA	NA	MYO1G	GBP3
ENSG00000261036	NA	2.18336112759448	0.00253933912677962	M2_vs_M1	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	ASB14
ENSG00000261094	NA	-1.66643592791022	2.62586395847409e-4	M2_vs_M1	HSALNG0074265	integenic	Q50	NA	Birth weight; Neuroimaging measurement; Brain volume measurement,-	RABGAP1	BEND3P2
ENSG00000261211	NA	2.08231728715152	7.04520791823596e-10	M2_vs_M1	HSALNG0047833	integenic	Q75	hsa-miR-6833-3p	Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,-	F13A1	HMGCR
ENSG00000261373	VPS9D1-AS1	-1.45227935508298	0.00488728280134929	M2_vs_M1	HSALNG0141629	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-4732-3p,hsa-miR-6808-5p	Blood protein measurement,Hair colour measurement,-	ZNF276	TOM1L1
ENSG00000261596	NA	-1.20164352778368	2.5791845105863997e-12	M2_vs_M1	HSALNG0110129	sense	Q75	NA	-	METTL9	EPHB2
ENSG00000261618	LINC02605	-5.66212835378757	6.061811912321999e-38	M2_vs_M1	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	ASS1
ENSG00000261625	NA	2.6412580920037	0.00128530535861323	M2_vs_M1	HSALNG0085289	integenic	Not conserved	NA	NA	MRGPRF	NDUFAF3
ENSG00000261644	CYLD-AS1	-2.07890430038206	1.1996062830391901e-17	M2_vs_M1	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	PLEKHG2
ENSG00000261888	NA	3.95643668287754	4.38000849919614e-26	M2_vs_M1	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	CMTM7
ENSG00000261971	MMP25-AS1	-4.04039087476127	3.50841956768383e-59	M2_vs_M1	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	PRDM4
ENSG00000262001	DLGAP1-AS2	-1.36208524307206	0.0495050116268419	M2_vs_M1	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	MTUS1-DT
ENSG00000262097	LINC02185	4.39283433472166	4.7434476206773897e-57	M2_vs_M1	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	SRGAP3
ENSG00000262151	NA	4.81698957434622	7.48917245106927e-8	M2_vs_M1	HSALNG0109562	anti_sense	Q50	hsa-miR-149-5p,hsa-miR-619-5p,hsa-miR-4463,hsa-miR-4774-5p,hsa-miR-6728-3p	Red blood cell density measurement; Erythrocyte count,Susceptibility to chronic sinus infection measurement,Nasopharyngeal neoplasm; Bmi-adjusted waist-hip ratio; Celiac disease,Ulcerative colitis,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Serum albumin measurement,-	DEXI	NOL4L
ENSG00000262468	LINC01569	-1.12147873995488	4.45707460472102e-6	M2_vs_M1	HSALNG0109218	integenic	Q50	hsa-miR-1233-5p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-1273h-5p	Pulse pressure measurement; Central corneal thickness,Electrocardiography; Alkaline phosphatase measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Red blood cell density measurement; Erythrocyte count,Pulse pressure measurement,Alkaline phosphatase measurement,Mean reticulocyte volume	SRL	VKORC1L1
ENSG00000263050	DPH1-AS1	-2.31522457303985	0.0103112670117211	M2_vs_M1	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6	MOB3C
ENSG00000263069	RNF213-AS1	-2.00799365249972	1.54251475879331e-16	M2_vs_M1	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	PLEKHA3
ENSG00000263120	NA	-2.13482860838284	0.0261985451332342	M2_vs_M1	HSALNG0117612	sense	Not conserved	NA	-	SCPEP1	TSEN15
ENSG00000263164	NA	3.1885401876083	0.0295602236239245	M2_vs_M1	HSALNG0114111	anti_sense,sense	Not conserved	NA	Head and neck squamous cell carcinoma,Family history of alzheimer’s disease,Sex hormone-binding globulin measurement,Leukocyte count,Red blood cell density measurement,-	SCIMP	ESPNL
ENSG00000263345	SGSM2-AS1	1.05027083643108	0.00879121501137693	M2_vs_M1	HSALNG0113905	anti_sense	Q75	hsa-miR-4313,hsa-miR-6132	Self reported educational attainment; Autism spectrum disorder,Lifestyle measurement,-,Household income	MNT	MICU2
ENSG00000263718	SEPTIN9-DT	1.55588462822902	0.00140469428979212	M2_vs_M1	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2	ENSG00000273145
ENSG00000264290	NA	1.7061594957215	0.00806046911023803	M2_vs_M1	HSALNG0115587	sense	Q75	hsa-miR-6775-3p	-	TP53I13	RALBP1P1
ENSG00000264456	NA	-1.20701376084405	2.61127559330737e-5	M2_vs_M1	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	RBBP4
ENSG00000264707	L3MBTL4-AS1	1.28095753236413	3.57149791652362e-5	M2_vs_M1	HSALNG0119795	anti_sense	Q50	NA	NA	ARHGAP28	ZNF273
ENSG00000265205	NA	-2.20054643044887	0.0190578866235918	M2_vs_M1	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2	P4HTM
ENSG00000265479	DTX2P1-UPK3BP1-PMS2P11	-5.17897334946866	0.0158486261118861	M2_vs_M1	HSALNG0059099	anti_sense,sense	Q75	NA	Body mass index,Waist-hip ratio; Body mass index,Urinary nitrogen measurement,Response to drug,Macrovascular complications of diabetes; Diabetic eye disease,Comparative body size at age 10, self-reported,Platinum measurement; Response to cisplatin,Interleukin-6 measurement,-	CCDC146	DTX2P1-UPK3BP1-PMS2P11
ENSG00000265678	NA	-2.51140315469175	0.00360533516784795	M2_vs_M1	HSALNG0119378	anti_sense	Q50	NA	NA	SLC16A3	ANKRD49P1
ENSG00000266049	NA	1.39865893553319	0.0151967886944971	M2_vs_M1	HSALNG0119656	anti_sense	Not conserved	hsa-miR-6089	Fat body mass,Nicotine withdrawal symptom count,Mathematical ability,Body height,Response to radiation,-,Conotruncal heart malformations	LPIN2	MAF1
ENSG00000266402	SNHG25	2.4123921076214	0.00238347379969695	M2_vs_M1	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	ARHGEF12
ENSG00000266708	NA	-5.04591543377038	0.0303033662995051	M2_vs_M1	HSALNG0119876	anti_sense	Q75	NA	-	PPP4R1	NR1D2
ENSG00000266709	NA	-4.63790422717215	3.57319626533838e-37	M2_vs_M1	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	PLTP
ENSG00000266718	NA	2.69868956285592	0.0450210319456836	M2_vs_M1	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	CNIH1
ENSG00000266835	GAPLINC	2.83668399295399	1.40830970445671e-44	M2_vs_M1	HSALNG0119710	sense	Not conserved	NA	Pr interval,Citrulline measurement,-	TGIF1	ZSCAN16-AS1
ENSG00000267026	NA	2.01411437624963	0.00369762555895725	M2_vs_M1	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	SLC4A7
ENSG00000267074	NA	-2.57511097834196	3.54605221981275e-5	M2_vs_M1	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	ENSG00000233785
ENSG00000267130	NA	3.54290744555337	0.00528504464935298	M2_vs_M1	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	PARD3B
ENSG00000267197	NA	-3.74582428768384	0.00228032878396727	M2_vs_M1	HSALNG0123939	sense	Not conserved	NA	NA	KEAP1	ENSG00000284734
ENSG00000267272	LINC01140	1.08755117108782	0.0261835570698467	M2_vs_M1	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	CRELD1
ENSG00000267288	NA	-5.17784486089691	0.0320209391785843	M2_vs_M1	HSALNG0116825	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-6802-5p	Balding measurement,-	PLCD3	FGFR4
ENSG00000267296	CEBPA-DT	2.0219536752372	6.019753522597719e-20	M2_vs_M1	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	FXN
ENSG00000267397	NA	2.11849845937941	0.0471425308214698	M2_vs_M1	HSALNG0120911	integenic	Not conserved	NA	NA	GALNT1	SSC5D
ENSG00000267452	LINC02073	2.9436899649777	9.12078612818145e-7	M2_vs_M1	HSALNG0117381	integenic	Not conserved	NA	NA	UTP18	LINC01500
ENSG00000267481	NA	1.38545260228152	0.0161358432458054	M2_vs_M1	HSALNG0124757	sense	Not conserved	hsa-miR-619-5p	-	ZNF506	FLOT1
ENSG00000267519	MIR23AHG	-1.17491241703197	3.20609995982846e-31	M2_vs_M1	HSALNG0124251	anti_sense	Q90	NA	Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1	CDK7
ENSG00000267549	ZSCAN5A-AS1	1.88415402938674	0.00184737051568975	M2_vs_M1	HSALNG0127749	anti_sense	Not conserved	NA	-	EDDM13	DDX55
ENSG00000267712	LINC01539	-6.77892098422525	7.15306980763215e-6	M2_vs_M1	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	FCAMR
ENSG00000267737	NA	-4.02954347840408	1.06678299055955e-8	M2_vs_M1	HSALNG0119029	integenic	Not conserved	NA	NA	PGS1	GATA2
ENSG00000267745	NA	-2.95668542264866	0.00354779369716964	M2_vs_M1	HSALNG0115943	integenic	Not conserved	NA	-	SLFN12	SYT15
ENSG00000267751	BSG-AS1	1.98261311419726	1.03316725073889e-6	M2_vs_M1	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	BCAN-AS1
ENSG00000268355	NA	1.69464271587497	0.0365948906635776	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	ZNF775
ENSG00000268895	A1BG-AS1	-1.12901499646474	5.26104244801387e-8	M2_vs_M1	HSALNG0127948	anti_sense	Not conserved	hsa-miR-1204,hsa-miR-4505,hsa-miR-4535,hsa-miR-4695-5p,hsa-miR-4707-5p,hsa-miR-6081	-	ZSCAN22	KCTD17
ENSG00000269072	NA	2.23168436524968	0.0201849498413364	M2_vs_M1	HSALNG0127186	anti_sense	Not conserved	hsa-miR-4463	Sialic acid-binding ig-like lectin 9 measurement,Blood protein measurement; Alkaline phosphatase measurement,Cortical thickness,Blood protein measurement,Granulocyte percentage of myeloid white cells; Blood protein measurement; Cerebrospinal fluid biomarker measurement; Monocyte percentage of leukocytes,Blood protein measurement; Reticulocyte measurement; Cerebrospinal fluid biomarker measurement,C-reactive protein measurement; Body mass index; Protein measurement; Sialic acid-binding ig-like lectin 9 measurement; Blood protein measurement,-	CTU1	COMMD4
ENSG00000269220	LINC00528	-2.36773987039613	2.52542245561277e-6	M2_vs_M1	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	C11orf16
ENSG00000269293	ZSCAN16-AS1	1.07379372739573	2.92867209804932e-8	M2_vs_M1	HSALNG0048933	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-7150	NA	OR2B8P	PTX3
ENSG00000269446	NA	1.37734886662478	1.86696845433284e-5	M2_vs_M1	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	ERLIN2
ENSG00000269553	NA	2.80745272619278	3.25791445800619e-5	M2_vs_M1	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	UBXN10
ENSG00000269667	NA	-5.04555505737218	0.0225398153675459	M2_vs_M1	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8	LGALS14
ENSG00000269889	NA	-5.17810099949161	0.0237953034768463	M2_vs_M1	HSALNG0030592	anti_sense	Q50	hsa-miR-941,hsa-miR-6816-5p	Sex hormone-binding globulin measurement; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil percentage of granulocytes; Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Lung adenocarcinoma,Neutrophil percentage of leukocytes,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Erythrocyte count,-	MYNN	IER3IP1
ENSG00000269959	SPACA6-AS1	-5.18004569891722	0.0230209926494461	M2_vs_M1	HSALNG0127249	anti_sense	Q75	NA	Calcium measurement,Body height,-	HAS1	FOXD4L1
ENSG00000269970	NA	1.76280885669838	7.09609172746085e-4	M2_vs_M1	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	CDK19
ENSG00000269982	NA	1.21559593819271	4.04613510827829e-6	M2_vs_M1	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	IFNAR1
ENSG00000270120	NA	-3.70235739397786	6.4262514342748e-7	M2_vs_M1	HSALNG0111360	sense	Q50	NA	NA	NOD2	TNPO2
ENSG00000270164	LINC01480	3.65740982902734	1.9943107532593797e-60	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	HOMER2
ENSG00000270426	NA	-1.00082086484313	0.00871487486921426	M2_vs_M1	HSALNG0039018	sense	Q90	NA	NA	IRF2	GPR171
ENSG00000270605	NA	-1.65567222449576	0.00258959843399192	M2_vs_M1	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	LINC01679
ENSG00000270607	NAV2-AS6	-1.76176264161768	4.06416344885316e-4	M2_vs_M1	HSALNG0083062	anti_sense	Q75	NA	-	DBX1	EXOC4
ENSG00000271032	NA	-3.41816082095267	3.83538298988597e-21	M2_vs_M1	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	PIM3
ENSG00000271040	TMEM242-DT	2.55447558959027	0.00318903441895943	M2_vs_M1	HSALNG0054615	anti_sense	Not conserved	NA	-	ZDHHC14	P2RY12
ENSG00000271086	NAMA	3.22367650632412	0.00245835796991076	M2_vs_M1	HSALNG0073233	integenic	Q75	hsa-miR-892b,hsa-miR-4279,hsa-miR-4638-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6504-5p,hsa-miR-6830-5p,hsa-miR-8485	Callous-unemotional behaviour; Body mass index,Mathematical ability,-	ALG2	RB1CC1
ENSG00000271474	UNC5C-AS1	-6.02389990272143	4.58938950188865e-4	M2_vs_M1	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	ART3
ENSG00000271643	PDCD6IP-DT	-1.45579240924446	4.5266192261219e-9	M2_vs_M1	HSALNG0025078	anti_sense	Not conserved	NA	-	CLASP2	TICAM2-AS1
ENSG00000271880	NA	1.66694527879193	0.00129244870675901	M2_vs_M1	NA	NA	NA	NA	NA	ADIRF	TRPV2
ENSG00000271926	NA	2.83123203932813	2.2230103335103702e-9	M2_vs_M1	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	PRRC1
ENSG00000271931	PNRC1-DT	-6.15903443437207	1.53869552200303e-4	M2_vs_M1	HSALNG0051848	integenic	Q50	hsa-miR-4492,hsa-miR-6803-5p,hsa-miR-6810-3p	Sleep duration	SRSF12	LGALS14
ENSG00000271952	LINC01954	2.60027820775933	0.00700254563012244	M2_vs_M1	HSALNG0146022	overlap_sense	Not conserved	NA	Childhood aggressive behaviour measurement,Chronotype measurement,Exploratory eye movement measurement,Neuropsychological test,Mathematical ability,Fev/fec ratio; Response to bronchodilator,-	KCNF1	PIGZ
ENSG00000272008	NA	-5.87400747408314	8.69396029387012e-4	M2_vs_M1	HSALNG0149464	anti_sense	Q75	NA	-	CGA	PLEKHA2
ENSG00000272068	BCAN-AS1	1.94519342045671	1.38891173404109e-4	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	BSG-AS1
ENSG00000272079	NA	1.49964859431372	0.00893789855730224	M2_vs_M1	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	ZFP57
ENSG00000272081	FCHO2-DT	2.8189964067603	2.0803550925580098e-22	M2_vs_M1	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	DMWD
ENSG00000272129	NA	2.67283407769174	0.0197127490483516	M2_vs_M1	HSALNG0051481	integenic	Q50	NA	NA	BCKDHB	ZNF223
ENSG00000272145	NFYC-AS1	-1.64367595776109	0.0169301393829378	M2_vs_M1	HSALNG0002891	anti_sense	Q90	hsa-miR-661,hsa-miR-4447,hsa-miR-4761-3p,hsa-miR-8072	Body height,-	RIMS3	ENSG00000285632
ENSG00000272172	NA	2.77443567635917	0.0452389072664529	M2_vs_M1	HSALNG0069270	anti_sense	Not conserved	hsa-miR-3960	Body height,-	TOP1MT	CLPP
ENSG00000272269	NUP153-AS1	-1.47334255521058	0.00666850579410369	M2_vs_M1	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	ARMT1
ENSG00000272335	NA	1.17167665701702	1.02424712729123e-6	M2_vs_M1	HSALNG0041565	integenic	Not conserved	NA	-	MRPS30	TTC3
ENSG00000272338	NA	1.78843456979391	0.0319011158388574	M2_vs_M1	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	CYP2S1
ENSG00000272341	NA	2.19572001072199	9.02768377798421e-16	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	SIGLEC6
ENSG00000272405	NA	1.27189968349664	3.18449533199288e-11	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	TSPO
ENSG00000272449	NA	-1.1087802118396901	3.3584787580744095e-11	M2_vs_M1	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	PEA15
ENSG00000272463	NA	-2.54139284711667	5.03029926902126e-4	M2_vs_M1	HSALNG0047304	integenic	Q50	NA	-	EXOC2	IRF5
ENSG00000272482	NA	4.7887224691508	0.0228896646775862	M2_vs_M1	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	EEF1A1P44
ENSG00000272555	NA	1.06301733860371	0.0143967915858871	M2_vs_M1	HSALNG0022299	integenic	Not conserved	NA	NA	CYP27A1	RPL7P50
ENSG00000272666	KLHDC7B-DT	-4.8723628534565	1.0614200891680401e-14	M2_vs_M1	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	EDARADD
ENSG00000272669	NA	-1.51601998124737	3.67773492178673e-4	M2_vs_M1	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	SPOCK2
ENSG00000272734	ADIRF-AS1	1.35216984908914	7.163049768957299e-12	M2_vs_M1	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2	TGIF1
ENSG00000272768	NA	1.09659956848714	0.0163200651027774	M2_vs_M1	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA	ENSG00000230747
ENSG00000272839	NA	1.56059712063451	0.00167096644251564	M2_vs_M1	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	KRT10
ENSG00000272894	MIOS-DT	-1.85715824531989	0.00705114112994896	M2_vs_M1	HSALNG0056056	anti_sense	Not conserved	hsa-miR-5571-3p	NA	COL28A1	USP53
ENSG00000272941	NA	-1.16102724596767	3.43702164136321e-4	M2_vs_M1	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	PSMA3-AS1
ENSG00000272986	NA	-5.04446728551147	0.0465722941651307	M2_vs_M1	HSALNG0035038	anti_sense	Q50	NA	NA	JCHAIN	MILR1
ENSG00000273002	ARHGEF2-AS2	-1.5249541323929099	3.5058650726483604e-9	M2_vs_M1	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	CHD9NB
ENSG00000273032	DGCR5	5.77038060385869	1.02288581117865e-15	M2_vs_M1	HSALNG0133984	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-764	NA	FAM246C	SH2B2
ENSG00000273143	DUSP5-DT	1.01780723539715	0.0341621253970342	M2_vs_M1	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	CX3CR1
ENSG00000273145	NA	1.00824499434695	0.0176098197117781	M2_vs_M1	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA	SEPTIN9-DT
ENSG00000273179	NA	1.59682715411742	0.00748043567873186	M2_vs_M1	HSALNG0032247	anti_sense	Not conserved	hsa-miR-23a-5p	NA	MAEA	SLC2A9
ENSG00000273226	NA	3.05238910271964	4.65784001830849e-9	M2_vs_M1	HSALNG0070293	anti_sense	Not conserved	NA	NA	DENND4C	UBA1
ENSG00000273272	NA	-5.0455603577719	0.0377400042802256	M2_vs_M1	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ZNF319
ENSG00000273314	NA	-2.73057446718504	2.24688212982998e-6	M2_vs_M1	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	PDLIM2
ENSG00000273341	NA	1.62487170059527	4.0407061095137696e-11	M2_vs_M1	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	EXOC5
ENSG00000273387	NA	3.0319978603835	3.65128573561023e-6	M2_vs_M1	HSALNG0134940	anti_sense	Q75	hsa-miR-762,hsa-miR-4447,hsa-miR-4505,hsa-miR-6735-5p	Fev/fec ratio,-	SELENOM	PPP6R3
ENSG00000273472	NA	-2.54099634591129	4.61814170344045e-39	M2_vs_M1	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	PIM3
ENSG00000273824	NA	-6.78982169254767	1.97278673904004e-32	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	UPK3B
ENSG00000273828	NA	-1.64216568138812	0.00174678203231763	M2_vs_M1	HSALNG0130476	anti_sense	Q50	NA	-	CD40	BTBD8
ENSG00000273855	NA	1.30171729020291	1.95047548409517e-4	M2_vs_M1	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	GTPBP3
ENSG00000273972	NA	-2.12648288623753	0.00871279969380134	M2_vs_M1	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	ENSG00000225200
ENSG00000274020	LINC01138	-1.822934009892	1.65622503976754e-8	M2_vs_M1	HSALNG0006866	integenic	Not conserved	NA	NA	PPIAL4G	CD72
ENSG00000274265	NA	-2.85391969074576	0.00227122262291734	M2_vs_M1	HSALNG0141909	integenic	Not conserved	hsa-miR-885-3p	-	PDE4DIP	DOCK9
ENSG00000274370	NA	2.37820147533611	9.16089611520357e-6	M2_vs_M1	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	ABCC10
ENSG00000274422	NA	2.43430944657704	2.77225197433704e-5	M2_vs_M1	HSALNG0134310	integenic	Not conserved	hsa-miR-6132,hsa-miR-8072	-	ZNF280B	ENSG00000226862
ENSG00000274461	LINC02930	4.59090639107174	3.0548037574975e-39	M2_vs_M1	HSALNG0081109	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4	MID1IP1
ENSG00000274508	NA	-2.31692398853707	8.03431859994107e-5	M2_vs_M1	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	ITIH2
ENSG00000274515	NA	-5.41396898349522	0.00459392464328298	M2_vs_M1	HSALNG0107305	intronic_antisense	Q50	hsa-miR-6787-3p	NA	SNX33	AMN
ENSG00000274536	MIR223HG	1.87086047392854	5.09259479177322e-5	M2_vs_M1	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH	LINS1
ENSG00000274565	NA	3.00129636676709	2.35102885224073e-4	M2_vs_M1	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	FBXW2
ENSG00000275120	NA	2.03445997699745	0.0326925782001963	M2_vs_M1	HSALNG0107802	integenic	Not conserved	NA	NA	WDR73	RANBP6
ENSG00000275180	NA	-1.38987418263118	9.55212904203231e-6	M2_vs_M1	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	TRPM2-AS
ENSG00000275278	NA	3.51822465459799	0.0107187042645383	M2_vs_M1	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	SIGLEC9
ENSG00000275431	NA	-5.30112631108009	0.0094194867498508	M2_vs_M1	HSALNG0115994	anti_sense	Q50	NA	Blood protein measurement,Eyelid sagging measurement,C-c motif chemokine 15 measurement	CCL18	ACOD1
ENSG00000276148	NA	1.92443430300479	0.0460172444195294	M2_vs_M1	HSALNG0090284	anti_sense	Q75	NA	NA	YARS2	PPP2R2D
ENSG00000276248	NA	1.06733395645029	0.042113397025515	M2_vs_M1	HSALNG0099603	sense	Not conserved	NA	NA	TMCO3	BICRAL
ENSG00000276462	LINC03025	-7.8363447603823	2.27018836849658e-74	M2_vs_M1	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	LGALS14
ENSG00000276476	LINC00540	-4.72624526857963	5.48744666536143e-9	M2_vs_M1	HSALNG0143794	integenic	Q50	NA	NA	FGF9	NOTCH4
ENSG00000277007	NA	4.07982759585304	3.2823821108195e-4	M2_vs_M1	HSALNG0010635	sense	Q75	NA	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1	ZPR1
ENSG00000277089	CCL3-AS1	3.9943108887293	1.46211025620395e-39	M2_vs_M1	HSALNG0116003	anti_sense,sense	Q75	hsa-miR-604,hsa-miR-4726-5p,hsa-miR-6077,hsa-miR-6089,hsa-miR-6743-5p	Blood protein measurement,C-c motif chemokine 3 measurement	CCL18	MAOA
ENSG00000277287	NA	1.24148910905104	0.002485761676603	M2_vs_M1	HSALNG0128242	integenic	Not conserved	NA	-	ITPA	AP1M1
ENSG00000277425	NA	-5.04524721635122	0.0277439632271876	M2_vs_M1	HSALNG0128363	sense	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	TMEM230	DCAF1
ENSG00000278112	NA	3.12759662813726	0.00288919000751706	M2_vs_M1	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p	NA	RILPL1	ENSG00000276248
ENSG00000278330	NA	1.38841543697993	2.90012956375351e-6	M2_vs_M1	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	WDR33
ENSG00000278869	NA	-1.26014848438123	0.0142939223777224	M2_vs_M1	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12	EOLA2
ENSG00000279277	NA	-1.18478705181293	6.43975000907771e-4	M2_vs_M1	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	MAN1B1-DT
ENSG00000279278	NA	2.29596798450305	7.9448644171252e-19	M2_vs_M1	HSALNG0134311	integenic	Not conserved	hsa-miR-198,hsa-miR-210-5p	NA	VPREB1	MIR600HG
ENSG00000279833	NA	1.37966418909407	0.00923410076924798	M2_vs_M1	NA	NA	NA	NA	NA	APOBEC3H	ENSG00000259094
ENSG00000280832	GSEC	-2.13817917633395	3.3416636156838e-7	M2_vs_M1	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	SPOCD1
ENSG00000281005	LINC00921	1.79926762317612	4.99052823518731e-7	M2_vs_M1	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	PARP3
ENSG00000281103	TRG-AS1	-1.31278704983793	6.8971022468796e-39	M2_vs_M1	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	SLC2A1
ENSG00000281392	LINC00506	-3.36295469201133	0.00370967584130515	M2_vs_M1	HSALNG0027226	integenic	Not conserved	NA	Prostate carcinoma,-	CHMP2B	NPDC1
ENSG00000281756	C2-AS1	-2.37242242451348	0.00940572632488637	M2_vs_M1	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	GJD3
ENSG00000281920	NA	6.17663833008349	1.37999085838429e-4	M2_vs_M1	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	SLC9A3-AS1
ENSG00000282164	PEG13	2.72086207317052	0.026692301093579	M2_vs_M1	HSALNG0150502	sense	Not conserved	NA	NA	TRAPPC9	SORCS2
ENSG00000282221	NA	-5.30245267386547	0.0170692955421875	M2_vs_M1	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1	CALY
ENSG00000282572	FAM157D	-1.75285636586144	0.0152826617591673	M2_vs_M1	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	GJB6
ENSG00000282851	BISPR	-1.10037479572472	2.97646632385545e-13	M2_vs_M1	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	ZFP36
ENSG00000283213	NA	1.62314814340427	7.1204525284144e-4	M2_vs_M1	HSALNG0110217	anti_sense	Q90	NA	-	USP31	IFT88
ENSG00000283633	NA	1.37876984460195	2.71075353176196e-6	M2_vs_M1	HSALNG0133812	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6784-5p	-	IL17RA	LGALS8
ENSG00000283648	NA	-7.01298771331557	2.61021178524595e-7	M2_vs_M1	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	ENSG00000289173
ENSG00000284240	LINC02801	2.58986292518036	0.0206302029332834	M2_vs_M1	HSALNG0004954	integenic	Q90	hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6085	Eosinophil count,Loneliness measurement,Basophil count,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Insomnia measurement,-	NA	MAPK3
ENSG00000284428	NA	1.193655447173	0.0394118690534579	M2_vs_M1	HSALNG0125033	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-632,hsa-miR-4318,hsa-miR-1268b,hsa-miR-4673,hsa-miR-4722-5p,hsa-miR-6075	Lysophosphatidylcholine 20:3 measurement,Hyperuricemia; Gout,Forced expiratory volume; Smoking status measurement,Pain measurement; Response to non-steroidal anti-inflammatory,-	NA	APPBP2-DT
ENSG00000284543	LINC01226	3.2064409875179	0.0387471104342357	M2_vs_M1	HSALNG0002236	sense	Q75	hsa-miR-1231,hsa-miR-1207-5p,hsa-miR-4434	Intelligence,-	TINAGL1	PRKDC
ENSG00000284633	NA	-3.48201449803627	8.01626726998057e-13	M2_vs_M1	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	DLG1
ENSG00000284669	NA	-1.89910368654652	0.00509273717345295	M2_vs_M1	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	GRSF1
ENSG00000284722	NA	3.6852939499209	0.00269393561067469	M2_vs_M1	NA	NA	NA	NA	NA	OR2AT4	SLC24A1
ENSG00000284734	NA	-5.18004648777736	0.0230383486380468	M2_vs_M1	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	ENSG00000267197
ENSG00000284882	NA	1.00087422757485	6.33163605911054e-6	M2_vs_M1	HSALNG0004813	anti_sense	Q50	NA	-	SPATA1	C9orf72
ENSG00000285190	NA	6.14714378796172	3.92088850196343e-5	M2_vs_M1	HSALNG0043300	anti_sense	Q50	hsa-miR-7703	Body mass index,Body height,-	RASA1	SMAD6
ENSG00000285239	NA	-5.41321345418204	0.00935600198140486	M2_vs_M1	HSALNG0142409	anti_sense	Not conserved	NA	NA	CD34	ENSG00000289530
ENSG00000285533	RELA-DT	1.09272905357433	6.35739203897223e-4	M2_vs_M1	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	H2BC4
ENSG00000285551	LINC02929	4.67479528617423	4.2272501244098e-7	M2_vs_M1	HSALNG0078329	sense	Q75	hsa-miR-4505,hsa-miR-1587,hsa-miR-5703	NA	NA	SP2
ENSG00000285632	NA	1.90343558556277	0.0310490666596241	M2_vs_M1	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5	TMEM120A
ENSG00000285736	NA	3.51825897942267	0.010711441323733	M2_vs_M1	HSALNG0045746	anti_sense	Not conserved	NA	-	IL17B	HSPB1P2
ENSG00000285744	NA	-5.77294763317168	4.3847733641903896e-141	M2_vs_M1	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	WARS1
ENSG00000285761	NA	-2.2330802272188	3.60178176203951e-6	M2_vs_M1	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	ZNF416
ENSG00000285863	NA	-1.16522678990167	0.0113000550571985	M2_vs_M1	HSALNG0144382	anti_sense	Not conserved	NA	Fev/fec ratio,-	C2CD4A	ENSG00000289261
ENSG00000285907	NA	-4.52055684496983	1.21008448603333e-7	M2_vs_M1	HSALNG0072614	integenic	Q50	hsa-miR-619-5p,hsa-miR-4455,hsa-miR-6826-3p	Body mass index; Metabolic syndrome,Risk-taking behaviour,Triglyceride measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Grip strength measurement; Body mass index,Visceral adipose tissue measurement,Body mass index,Chronotype measurement,Fibrinogen measurement; Cortical thickness,Cleft lip; Cleft palate,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Triglyceride measurement; Chronotype measurement,Neuroimaging measurement; Brain measurement,Age at menarche,Cortical surface area measurement; Hemoglobin measurement; Hematocrit; Mathematical ability,Hematocrit,Cognitive function measurement,Mathematical ability,-	SEMA4D	C16orf87
ENSG00000285966	NA	-3.31884288531664	4.35908247211722e-5	M2_vs_M1	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL	LY96
ENSG00000286004	NA	-1.56127241884144	0.00109150944814249	M2_vs_M1	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	ENSG00000262482
ENSG00000286062	NA	1.18681702820862	1.1808318254456e-5	M2_vs_M1	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	DDIAS
ENSG00000286067	NA	-1.47449701178921	6.360904241478491e-14	M2_vs_M1	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	RIGI
ENSG00000286129	NA	1.3226887592751	0.00553316123653945	M2_vs_M1	HSALNG0134321	integenic	Not conserved	NA	-	VPREB1	NME6
ENSG00000286162	NA	-2.44889233154783	1.55318688929537e-24	M2_vs_M1	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	JAK2
ENSG00000286174	NA	-5.08934774523657	1.1367153291681499e-28	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	RAP2C
ENSG00000286176	NA	3.12789161461974	0.00286274327022251	M2_vs_M1	HSALNG0032624	anti_sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Drugs used in diabetes use measurement,Glucose measurement,Hba1c measurement,-,Cholesteryl ester 16:0 measurement,Longevity	PPP2R2C	PIK3CB
ENSG00000286248	NA	-1.17715039495422	0.00526235770683614	M2_vs_M1	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	ENSG00000247903
ENSG00000286276	NA	-1.42175040279412	0.007757732342217	M2_vs_M1	HSALNG0006333	integenic	Q50	hsa-miR-615-5p,hsa-miR-4519	Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Stressful life event measurement; Depressive symptom measurement,-	ATP1A1	GSE1
ENSG00000286481	NA	3.821148651471	9.15499744267781e-13	M2_vs_M1	HSALNG0018495	integenic	Not conserved	NA	NA	TSN	TMEM106B
ENSG00000286504	NA	-6.02389352054178	4.48224694632565e-4	M2_vs_M1	HSALNG0089056	integenic	Not conserved	NA	NA	FAM90A1	ZNF132
ENSG00000286546	NA	3.24198177378189	7.28698386240258e-20	M2_vs_M1	HSALNG0128824	anti_sense	Not conserved	NA	Cognitive impairment measurement,High density lipoprotein cholesterol measurement; Response to diuretic,-	KIF16B	PYGL
ENSG00000286548	NA	-2.36280871483439	1.34942842962294e-10	M2_vs_M1	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	TRIM26
ENSG00000286558	NA	-2.18836462404564	0.00313467977268302	M2_vs_M1	HSALNG0148220	integenic	Not conserved	NA	-	TMEM144	TOMM20P2
ENSG00000286646	MAP3K5-AS2	3.6490337388593	8.705276051642041e-85	M2_vs_M1	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	RIN3
ENSG00000286696	NA	1.30211225837521	0.0192779650401734	M2_vs_M1	HSALNG0144397	anti_sense	Q75	NA	NA	CCDC33	FKBP9
ENSG00000286698	NA	5.50708645380734	0.00382359593087501	M2_vs_M1	HSALNG0016845	integenic	Not conserved	NA	NA	EIF2AK3	RFX4
ENSG00000286707	NA	3.24205572005014	0.00108041073238992	M2_vs_M1	HSALNG0013717	anti_sense,sense	Q90	NA	Non-small cell lung carcinoma,-	SELENOI	PIK3C2B
ENSG00000286757	NA	1.21774842400249	0.0207182364876274	M2_vs_M1	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5	ACADM
ENSG00000286872	NA	2.74274736141984	4.84886463259652e-50	M2_vs_M1	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	PAK1
ENSG00000286972	NA	3.40275038000893	1.44832250146622e-14	M2_vs_M1	HSALNG0146843	integenic	Q90	NA	Abnormal paneth cell measurement,-	TOP1	JDP2
ENSG00000287024	NA	2.59966818908984	0.0123914355031671	M2_vs_M1	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p	NA	APLN	UROS
ENSG00000287074	NA	2.35530720073601	0.0415267063450897	M2_vs_M1	HSALNG0143356	sense	Not conserved	NA	NA	AEBP2	GORAB
ENSG00000287091	NA	1.53423919544629	0.014495337107614	M2_vs_M1	HSALNG0146641	sense	Q50	hsa-miR-1203	NA	CD302	TSC22D1
ENSG00000287123	NA	3.59630917653852	2.76209356375687e-4	M2_vs_M1	HSALNG0146118	integenic	Q50	hsa-miR-619-5p,hsa-miR-4437,hsa-miR-6124,hsa-miR-6813-5p	-	SLC1A4	ZMYND11
ENSG00000287245	NA	1.88140702477932	0.0176499553429206	M2_vs_M1	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	CCDC88A
ENSG00000287255	NA	2.72928507404226	6.65148546815724e-4	M2_vs_M1	HSALNG0014389	anti_sense	Q50	hsa-miR-619-5p	Qt interval; Pr interval,Qt interval,Pr interval,Protein measurement,Qt interval; Tpe interval measurement,Electrocardiography,Bone fracture,Dna methylation,Heel bone mineral density,Forced expiratory volume; Response to bronchodilator,-	TMEM178A	RBP1
ENSG00000287263	NA	-1.99397160506587	2.6594178979513797e-60	M2_vs_M1	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	C1RL
ENSG00000287265	NA	-1.47429079415491	0.00118347848663637	M2_vs_M1	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	FUS
ENSG00000287335	NA	-5.41370375023556	0.00625872341574741	M2_vs_M1	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	ENSG00000287335
ENSG00000287415	NA	4.59769460115068	8.949364812672401e-16	M2_vs_M1	HSALNG0025355	integenic	Q50	hsa-miR-8485	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,Heel bone mineral density,Hip bone mineral density,Testosterone measurement; Systolic blood pressure,Testosterone measurement,Hypermetropia; Bone density; Myopia,Bone density,Femoral neck bone mineral density; Bone fracture,Bone density; Heel bone mineral density,Drugs affecting bone structure and mineralization use measurement,Femoral neck bone mineral density; Spine bone mineral density,Osteoporosis,Lean body mass; Bone density,Adolescent idiopathic scoliosis,Systolic blood pressure,Myopia,Mean arterial pressure,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Response to amisulpride; Longitudinal bmi measurement,Refractive error,-	ZNF621	LCA5L
ENSG00000287494	NA	1.34742614403133	0.00619867071794463	M2_vs_M1	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	MTATP6P1
ENSG00000287497	NA	2.71926453989378	2.48810356543792e-6	M2_vs_M1	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	TIGAR
ENSG00000287543	NA	-3.81830230955556	1.86990475367665e-17	M2_vs_M1	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	ENSG00000254287
ENSG00000287576	NA	-2.45791287741415	9.23393916517637e-11	M2_vs_M1	HSALNG0150312	integenic	Not conserved	NA	Leukocyte count	GSDMD	NRG2
ENSG00000287691	NA	-2.48548060179865	7.19936761840199e-5	M2_vs_M1	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	FTX
ENSG00000287733	NA	-1.00676572327275	3.48357082640507e-6	M2_vs_M1	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	SLC25A34
ENSG00000287736	PTCSC1	1.20920536632996	0.0128383806947544	M2_vs_M1	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	KLHDC8B
ENSG00000287771	NA	5.29230145893934	0.00526235770683614	M2_vs_M1	HSALNG0017397	integenic	Q50	NA	Ulcerative colitis; Crohn's disease,Autism spectrum disorder; Ulcerative colitis; Ankylosing spondylitis; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder,-	IL1R1	ADAMTSL2
ENSG00000287778	NA	2.05181925996797	6.20022420742388e-7	M2_vs_M1	HSALNG0032926	integenic	Not conserved	NA	NA	DRD5	ACTG1
ENSG00000287809	NA	2.79296254338363	0.00956417205742225	M2_vs_M1	HSALNG0110117	anti_sense,sense	Not conserved	NA	Velopharyngeal dysfunction,Adolescent idiopathic scoliosis,Empathy measurement,Unipolar depression,Major depressive disorder; Unipolar depression,Balding measurement,Inflammatory biomarker measurement; Ykl40 measurement,Bipolar disorder; Unipolar depression; Disease recurrence,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	METTL9	ENSG00000289080
ENSG00000287839	NA	-2.06698691737017	2.35690091652643e-19	M2_vs_M1	HSALNG0007520	integenic	Not conserved	NA	Neutrophil count	YY1AP1	COG5
ENSG00000287893	NA	3.6576391130606	0.00655705440277273	M2_vs_M1	HSALNG0057241	integenic	Not conserved	NA	-	HERPUD2	LINC02925
ENSG00000287917	NA	-1.24714046058956	0.00409464180017411	M2_vs_M1	HSALNG0084879	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3620-3p,hsa-miR-6089,hsa-miR-6803-5p	-	SLC25A45	ENSG00000288748
ENSG00000287978	NA	2.15302225912197	0.0165911835376322	M2_vs_M1	HSALNG0141895	integenic	Not conserved	NA	NA	POLR3GL	GZMK
ENSG00000288066	NA	1.01580587226977	7.83542498414503e-4	M2_vs_M1	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	MT-RNR2
ENSG00000288700	NA	3.23953348539127	3.82759276299642e-12	M2_vs_M1	HSALNG0147628	intronic_sense	Q50	NA	NA	CEP63	VLDLR
ENSG00000288743	NA	2.01412457066987	0.0085985478230537	M2_vs_M1	HSALNG0097024	overlap_antisense,anti_sense	Q50	hsa-miR-4480,hsa-miR-6747-5p,hsa-miR-7155-5p	Uterine fibroid,-	CAB39L	TRA2A
ENSG00000288754	NA	1.90053644081471	2.02344348933772e-7	M2_vs_M1	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	YOD1
ENSG00000288767	NA	-4.18719264033172	7.40678083214146e-10	M2_vs_M1	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	PTGES3P1
ENSG00000288819	NA	-2.4653154481947	0.00335998657322287	M2_vs_M1	NA	NA	NA	NA	NA	CATIP	ZNF554
ENSG00000288919	NA	-3.34643184372607	0.0176317096488933	M2_vs_M1	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	THYN1
ENSG00000288927	NA	2.18297876613344	0.00513175801354018	M2_vs_M1	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	MIR3667HG
ENSG00000288928	NA	2.01411831388387	0.00342886823974593	M2_vs_M1	NA	NA	NA	NA	NA	HIF1A	CCSAP
ENSG00000288954	NA	-8.70536254459186	2.22588509024751e-22	M2_vs_M1	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	FNBP4
ENSG00000288961	NA	-1.53356450823113	6.57760971118802e-6	M2_vs_M1	HSALNG0116727	integenic	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4508,hsa-miR-6816-5p	-	RUNDC3A	M1AP
ENSG00000289015	NA	1.00260754950868	0.0444337747978021	M2_vs_M1	HSALNG0058614	anti_sense	Not conserved	NA	-	SBDS	ASB14
ENSG00000289053	NA	-3.15228385208134	2.18557459135641e-4	M2_vs_M1	HSALNG0056798	integenic	Q50	NA	Interleukin 18 measurement,Gestational age,Monocyte percentage of leukocytes,-	NFE2L3	DCAF11
ENSG00000289070	NA	4.30151676698181	5.536724315405249e-31	M2_vs_M1	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	LY9
ENSG00000289071	NA	-2.9515400013351	0.0319337558314048	M2_vs_M1	NA	NA	NA	NA	NA	CD46	ACRBP
ENSG00000289080	NA	2.03026296308537	9.39828129478734e-4	M2_vs_M1	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	RABEP2	SNX32
ENSG00000289092	NA	-2.09633364396497	2.59082181056816e-9	M2_vs_M1	HSALNG0077924	anti_sense	Not conserved	hsa-miR-1273h-5p	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Erythrocyte count	TIMM23	MAMDC4
ENSG00000289100	NA	-2.90995045690792	7.97930711075998e-9	M2_vs_M1	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p	NA	PFDN6	RN7SL368P
ENSG00000289127	NA	4.81200662390581	6.35473931137456e-8	M2_vs_M1	HSALNG0137342	integenic	Q90	NA	NA	MID1IP1	DDX59
ENSG00000289161	NA	-1.36092879930899	5.77933507655398e-13	M2_vs_M1	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	PER3
ENSG00000289173	NA	-5.70759311078317	0.00242891600666816	M2_vs_M1	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	OSR2
ENSG00000289197	NA	-4.73450443688101	0.0483087909901335	M2_vs_M1	HSALNG0039059	integenic	Not conserved	NA	Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	HELT	LGALS14
ENSG00000289198	NA	-1.99537876739599	6.48296364514337e-5	M2_vs_M1	HSALNG0052920	integenic	Q90	NA	-	MARCKS	QRSL1
ENSG00000289298	NA	1.48272481778849	1.67224957458355e-4	M2_vs_M1	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	ENSG00000279433
ENSG00000289331	NA	-4.89857023745046	0.0422005387985445	M2_vs_M1	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	BLACAT1
ENSG00000289351	NA	2.39956484348091	1.30691941541889e-4	M2_vs_M1	HSALNG0028867	integenic	Not conserved	NA	NA	COPG1	ENSG00000229337
ENSG00000289365	NA	-3.24674065255735	1.08913267662298e-6	M2_vs_M1	HSALNG0139497	integenic	Q50	NA	NA	NXT2	KCNE5
ENSG00000289372	NA	-5.30013877641049	0.0171674067414139	M2_vs_M1	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC	PLEKHS1
ENSG00000289530	NA	-5.41308530521378	0.0112657776074932	M2_vs_M1	HSALNG0035158	integenic	Q50	NA	-	RASSF6	ENSG00000289530
ENSG00000289548	NA	5.98174735409444	2.54350305358624e-4	M2_vs_M1	HSALNG0146881	integenic	Not conserved	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6859-3p	NA	SLCO4A1	ATP5F1BP1
ENSG00000289564	NA	2.87345826606989	0.0109378493135623	M2_vs_M1	HSALNG0134258	anti_sense	Not conserved	hsa-miR-619-5p	NA	PPIL2	MLXIP
ENSG00000289582	NA	-5.14213842893033	4.612362192610529e-30	M2_vs_M1	NA	NA	NA	NA	NA	GBP2	ENSG00000291086
ENSG00000289587	NA	3.37448568365572	0.0130207102505907	M2_vs_M1	HSALNG0118245	anti_sense	Q50	NA	Post-traumatic stress disorder	APOH	MAML2
ENSG00000289589	NA	-6.28288201311157	6.69884624990414e-5	M2_vs_M1	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	CARMIL3
ENSG00000289618	NA	2.35485498339535	0.0201853204240725	M2_vs_M1	HSALNG0112251	anti_sense,sense	Not conserved	NA	Eosinophil count,High density lipoprotein cholesterol measurement,-	DUS2	NR1D1
ENSG00000289691	NA	-1.02330145953542	0.0496651949262178	M2_vs_M1	HSALNG0060000	sense	Q75	hsa-miR-619-5p	-	PILRA	ENSG00000259762
ENSG00000289725	NA	3.24683347801064	8.95804201589029e-4	M2_vs_M1	HSALNG0071598	integenic	Not conserved	NA	NA	ZNG1E	ERMN
ENSG00000289844	NA	-5.30063166239226	0.0145252956571758	M2_vs_M1	HSALNG0102515	integenic	Q75	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089,hsa-miR-6769a-3p	Periodontitis,Basophil count; Basophil percentage of leukocytes,Total blood protein measurement,-	FOS	LPAR4
ENSG00000289880	NA	-3.96901334014938	2.46881154964357e-10	M2_vs_M1	NA	NA	NA	NA	NA	FAM177B	TRBV5-4
ENSG00000289881	NA	3.18853328551924	0.0295529010738251	M2_vs_M1	HSALNG0004816	integenic	Not conserved	hsa-miR-4534,hsa-miR-5047,hsa-miR-6830-5p	Survival time; Lung carcinoma,-	SSX2IP	ENSG00000289881
ENSG00000289942	NA	-5.17910798849494	0.0117886023845329	M2_vs_M1	NA	NA	NA	NA	NA	TMPRSS11E	SLC8A3
ENSG00000289947	NA	-3.12471430453319	0.0200861805780636	M2_vs_M1	NA	NA	NA	NA	NA	ODF3B	WWC3
ENSG00000289958	NA	4.7886045090689	0.0205219400802472	M2_vs_M1	HSALNG0048244	integenic	Not conserved	NA	-	MCUR1	PHF13
ENSG00000289977	NA	3.08996523968364	1.31021054491669e-6	M2_vs_M1	HSALNG0114255	integenic	Not conserved	NA	NA	ACADVL	LTA4H
ENSG00000290034	NA	1.17384525128847	0.00163017615935582	M2_vs_M1	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	ENSG00000274508
ENSG00000290041	NA	-1.91397458407335	7.12205360765858e-13	M2_vs_M1	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	WAKMAR2
ENSG00000290054	NA	5.6152992234254	3.85572293055772e-4	M2_vs_M1	HSALNG0031957	sense	Not conserved	NA	NA	PIGX	WBP1L
ENSG00000290095	NA	2.99561929601739	0.00816769622571749	M2_vs_M1	NA	NA	NA	NA	NA	GALNTL5	IGSF3
ENSG00000290385	NA	-2.26254155028471	0.0057746890116276	M2_vs_M1	HSALNG0000017	integenic	Not conserved	NA	NA	OR4F29	GCC1
ENSG00000290394	NA	-2.552160414233	0.0143148529444514	M2_vs_M1	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3	PPP1R1A
ENSG00000290399	NA	-3.60500432199171	5.69963677023299e-6	M2_vs_M1	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	C22orf42
ENSG00000290418	TPTEP1	1.2956609299182	1.56333736889853e-14	M2_vs_M1	HSALNG0133819	integenic	Not conserved	NA	-	IL17RA	ECH1
ENSG00000290427	NA	1.55572863683271	1.55215738419587e-21	M2_vs_M1	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	HS2ST1
ENSG00000290441	NA	-5.7067422047251	0.00229246930078081	M2_vs_M1	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	PLCB4
ENSG00000290525	GBP1P1	-7.25250770825806	1.07329454222296e-51	M2_vs_M1	NA	NA	NA	NA	NA	GBP6	OR2I1P
ENSG00000290644	NA	2.7231936240913	0.0220139915689092	M2_vs_M1	HSALNG0072753	integenic	Not conserved	hsa-miR-3178,hsa-miR-4505,hsa-miR-6514-3p	-	CENPP	C14orf119
ENSG00000290710	HLA-V	-2.67044821962718	5.57309361828541e-5	M2_vs_M1	NA	NA	NA	NA	NA	HLA-G	HLA-A
ENSG00000290718	FAM95B1	3.15867390557857	5.22861094986125e-4	M2_vs_M1	HSALNG0071261	integenic	Not conserved	NA	-	SPATA31A1	IGLV2-11
ENSG00000290727	ALMS1P1	-5.95029395718876	6.27759254172367e-4	M2_vs_M1	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	CBX4
ENSG00000290735	NA	-4.03551738849199	1.13712963460472e-4	M2_vs_M1	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	GPC5
ENSG00000290838	NCF1B	-7.36015716641848	1.8061513923746302e-9	M2_vs_M1	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	MT1E
ENSG00000290858	NA	-6.34063468311214	7.36163552875515e-5	M2_vs_M1	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM	MMP10
ENSG00000290866	OTOAP1	3.7138703718003	4.96254053372056e-22	M2_vs_M1	NA	NA	NA	NA	NA	NPIPB5	MZT2A
ENSG00000290867	LINC01145	-1.79455123455786	1.95117730387184e-5	M2_vs_M1	HSALNG0142314	integenic	Not conserved	NA	-	PPIAL4D	RELA-DT
ENSG00000290873	LINC03009	-1.74669825650773	1.79953777593887e-5	M2_vs_M1	NA	NA	NA	NA	NA	UPK3B	ENSG00000265798
ENSG00000290927	NA	-2.09434770373186	2.3560757200028397e-34	M2_vs_M1	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	DNM3
ENSG00000290928	NA	1.1601661481056	0.00388302463213941	M2_vs_M1	HSALNG0115658	integenic	Not conserved	NA	NA	ATAD5	F12
ENSG00000290999	NA	-3.36079909441054	4.00279722384643e-5	M2_vs_M1	NA	NA	NA	NA	NA	SEC22B	IL36RN
ENSG00000291005	NBPF25P	1.91701329993796	7.2502390800734e-5	M2_vs_M1	HSALNG0006737	anti_sense	Not conserved	NA	Breast carcinoma,-	PDZK1	DCTN3
ENSG00000291006	NA	-1.56889354313616	2.3780250994682e-10	M2_vs_M1	NA	NA	NA	NA	NA	TMEM14A	FSD1L
ENSG00000291040	CD99P1	2.92565401273014	6.23773744711954e-23	M2_vs_M1	HSALNG0136380	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	CD99	IFT80
ENSG00000291049	FAM86B3P	1.20488711434981	1.67745924286101e-4	M2_vs_M1	NA	NA	NA	NA	NA	ZNF705B	RPS18
ENSG00000291086	LGALS17A	-5.96344175145771	8.052681719225469e-22	M2_vs_M1	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	ENSG00000289582
ENSG00000291091	SDHAP4	1.24406775574897	1.04793575874512e-34	M2_vs_M1	HSALNG0032044	integenic	Not conserved	hsa-miR-4281	NA	BDH1	TBXAS1
ENSG00000291097	HLA-L	-1.69516570111567	1.789426902127e-16	M2_vs_M1	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	H4C8
ENSG00000291104	BTN2A3P	-1.2104826113007	4.5231955515222e-5	M2_vs_M1	HSALNG0048771	integenic	Not conserved	NA	NA	BTN3A1	MKLN1
ENSG00000291114	SIGLEC17P	1.67153208613902	1.0730586866751702e-15	M2_vs_M1	NA	NA	NA	NA	NA	SIGLEC7	ZNF551
ENSG00000291135	FCGR1BP	-3.56425493439179	4.20660140287808e-13	M2_vs_M1	NA	NA	NA	NA	NA	SRGAP2C	LINC02541
ENSG00000291143	NA	-2.31602438369323	1.8833149657845097e-19	M2_vs_M1	NA	NA	NA	NA	NA	OR2AG2	TLK2
ENSG00000291155	CT75	-5.11314516746684	3.8406800728957594e-11	M2_vs_M1	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2	MT1E
ENSG00000291158	LINC00869	-2.18185411919082	5.78970294242386e-7	M2_vs_M1	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	AK9
ENSG00000291173	CASP4LP	-3.06559525681454	1.3736167721514e-5	M2_vs_M1	NA	NA	NA	NA	NA	CASP12	COPS2
ENSG00000291174	NA	-1.76090792288599	7.72287845804177e-4	M2_vs_M1	NA	NA	NA	NA	NA	FRMD8	LIN52
ENSG00000291178	NA	-1.32158754559974	0.0373174143549046	M2_vs_M1	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimer’s disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1	NCALD
ENSG00000291186	NA	1.27016781382007	7.89485025846071e-4	M2_vs_M1	NA	NA	NA	NA	NA	DEFB108B	ENSG00000289470
ENSG00000291223	FAM86DP	1.49749576250834	1.10689686919524e-11	M2_vs_M1	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	RBBP7
ENSG00000291224	NA	1.143755444058	0.0121495450388947	M2_vs_M1	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2	WWOX
ENSG00000291233	NA	-1.31158875472878	0.047674900746561	M2_vs_M1	NA	NA	NA	NA	NA	NBPF9	TAF13
ENSG00000291236	NA	-3.2912859115241	0.00663065491991384	M2_vs_M1	NA	NA	NA	NA	NA	TNS1	FAM107A
ENSG00000291258	NA	-3.21162559922289	0.00845586190991785	M2_vs_M1	HSALNG0144341	overlap_antisense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	APBA2	UTP25
